JPH0425268B2 - - Google Patents
Info
- Publication number
- JPH0425268B2 JPH0425268B2 JP58209713A JP20971383A JPH0425268B2 JP H0425268 B2 JPH0425268 B2 JP H0425268B2 JP 58209713 A JP58209713 A JP 58209713A JP 20971383 A JP20971383 A JP 20971383A JP H0425268 B2 JPH0425268 B2 JP H0425268B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- lower alkoxy
- acid
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 125000003545 alkoxy group Chemical group 0.000 claims description 42
- 125000004432 carbon atom Chemical group C* 0.000 claims description 18
- 150000002212 flavone derivatives Chemical class 0.000 claims description 16
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 9
- 125000004423 acyloxy group Chemical group 0.000 claims description 8
- 125000005201 cycloalkylcarbonyloxy group Chemical group 0.000 claims description 8
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- -1 t-butoxy group Chemical group 0.000 description 52
- 150000001875 compounds Chemical class 0.000 description 47
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- 238000006243 chemical reaction Methods 0.000 description 28
- 239000000243 solution Substances 0.000 description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 239000003054 catalyst Substances 0.000 description 18
- 235000019441 ethanol Nutrition 0.000 description 18
- 239000012442 inert solvent Substances 0.000 description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 17
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 12
- 239000003826 tablet Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 description 11
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 11
- 208000006673 asthma Diseases 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 229920002472 Starch Polymers 0.000 description 10
- 235000019698 starch Nutrition 0.000 description 10
- 239000008107 starch Substances 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 150000002170 ethers Chemical class 0.000 description 8
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 7
- 150000001298 alcohols Chemical class 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 239000008101 lactose Substances 0.000 description 7
- 239000000825 pharmaceutical preparation Substances 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 6
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- UGYAAQGCLTXEKY-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-6-hexoxy-5,7-dimethoxychromen-4-one Chemical compound C=1C(=O)C2=C(OC)C(OCCCCCC)=C(OC)C=C2OC=1C1=CC=C(O)C(O)=C1 UGYAAQGCLTXEKY-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 description 5
- 235000011054 acetic acid Nutrition 0.000 description 5
- 150000007514 bases Chemical class 0.000 description 5
- 238000006900 dealkylation reaction Methods 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- 206010030111 Oedema mucosal Diseases 0.000 description 4
- 150000008065 acid anhydrides Chemical class 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 150000001350 alkyl halides Chemical class 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 238000005947 deacylation reaction Methods 0.000 description 4
- 230000020335 dealkylation Effects 0.000 description 4
- 238000006264 debenzylation reaction Methods 0.000 description 4
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 4
- 150000004820 halides Chemical class 0.000 description 4
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- XBJHWLTXHYIOHY-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-6-dodecoxy-5,7-dimethoxychromen-4-one Chemical compound C=1C(=O)C2=C(OC)C(OCCCCCCCCCCCC)=C(OC)C=C2OC=1C1=CC=C(O)C(O)=C1 XBJHWLTXHYIOHY-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- RDSMTNKWYACDBJ-UHFFFAOYSA-N [2-acetyloxy-4-(6-hexoxy-5,7-dimethoxy-4-oxochromen-2-yl)phenyl] acetate Chemical compound C=1C(=O)C2=C(OC)C(OCCCCCC)=C(OC)C=C2OC=1C1=CC=C(OC(C)=O)C(OC(C)=O)=C1 RDSMTNKWYACDBJ-UHFFFAOYSA-N 0.000 description 3
- 238000005917 acylation reaction Methods 0.000 description 3
- 235000012211 aluminium silicate Nutrition 0.000 description 3
- 239000000924 antiasthmatic agent Substances 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 3
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000007884 disintegrant Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000003380 propellant Substances 0.000 description 3
- 235000019260 propionic acid Nutrition 0.000 description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 3
- 230000008728 vascular permeability Effects 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- 229940124125 5 Lipoxygenase inhibitor Drugs 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 2
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 229940125715 antihistaminic agent Drugs 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- CHIHQLCVLOXUJW-UHFFFAOYSA-N benzoic anhydride Chemical compound C=1C=CC=CC=1C(=O)OC(=O)C1=CC=CC=C1 CHIHQLCVLOXUJW-UHFFFAOYSA-N 0.000 description 2
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 2
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 235000001046 cacaotero Nutrition 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- JRFZSUMZAUHNSL-UHFFFAOYSA-N chrysin 5,7-dimethyl ether Chemical compound C=1C(OC)=CC(OC)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 JRFZSUMZAUHNSL-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 150000008050 dialkyl sulfates Chemical class 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- MYTMXVHNEWBFAL-UHFFFAOYSA-L dipotassium;carbonate;hydrate Chemical compound O.[K+].[K+].[O-]C([O-])=O MYTMXVHNEWBFAL-UHFFFAOYSA-L 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 2
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 150000002617 leukotrienes Chemical class 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 230000016160 smooth muscle contraction Effects 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- 238000006276 transfer reaction Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 229940075420 xanthine Drugs 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- IAFBOKYTDSDNHV-UHFFFAOYSA-N (2S)-(-)-5,7-dimethoxyflavanone Natural products O1C2=CC(OC)=CC(OC)=C2C(=O)CC1C1=CC=CC=C1 IAFBOKYTDSDNHV-UHFFFAOYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- VQTDPCRSXHFMOL-UHFFFAOYSA-N 2,4-Dimethoxyacetophenone Chemical compound COC1=CC=C(C(C)=O)C(OC)=C1 VQTDPCRSXHFMOL-UHFFFAOYSA-N 0.000 description 1
- QUVUDKJWDNXENX-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-6-dodecoxy-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(=O)C2=C(O)C(OCCCCCCCCCCCC)=C(OC)C=C2OC=1C1=CC=C(O)C(O)=C1 QUVUDKJWDNXENX-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- ZLWMGDNHFWGWLW-UHFFFAOYSA-N 3,4-bis(phenylmethoxy)benzoyl chloride Chemical compound C=1C=CC=CC=1COC1=CC(C(=O)Cl)=CC=C1OCC1=CC=CC=C1 ZLWMGDNHFWGWLW-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 208000016557 Acute basophilic leukemia Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 238000003694 Baker-Venkataraman reaction Methods 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbeccoâs modiï¬ed Eagle's medium Substances 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,Nâdiethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- 208000002200 Respiratory Hypersensitivity Diseases 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- DSVGQVZAZSZEEX-UHFFFAOYSA-N [C].[Pt] Chemical compound [C].[Pt] DSVGQVZAZSZEEX-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 230000010085 airway hyperresponsiveness Effects 0.000 description 1
- 238000005882 aldol condensation reaction Methods 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000010338 boric acid Nutrition 0.000 description 1
- 125000005619 boric acid group Chemical class 0.000 description 1
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 230000020176 deacylation Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 238000010931 ester hydrolysis Methods 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- KTDNMEKSWIWCQY-UHFFFAOYSA-N formic acid;sodium Chemical compound [Na].OC=O.OC=O KTDNMEKSWIWCQY-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 125000005446 heptyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- YWGHUJQYGPDNKT-UHFFFAOYSA-N hexanoyl chloride Chemical compound CCCCCC(Cl)=O YWGHUJQYGPDNKT-UHFFFAOYSA-N 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- DBTMGCOVALSLOR-VPNXCSTESA-N laminarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](O)C(O[C@H]2[C@@H]([C@@H](CO)OC(O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-VPNXCSTESA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- XTFSPXGZPDPJNB-UHFFFAOYSA-N n-ethyl-n-propan-2-ylpropan-2-amine;pyridine Chemical compound C1=CC=NC=C1.CCN(C(C)C)C(C)C XTFSPXGZPDPJNB-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 230000018791 negative regulation of catalytic activity Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 125000006611 nonyloxy group Chemical group 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 125000005447 octyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- BWILYWWHXDGKQA-UHFFFAOYSA-M potassium propanoate Chemical compound [K+].CCC([O-])=O BWILYWWHXDGKQA-UHFFFAOYSA-M 0.000 description 1
- 239000004331 potassium propionate Substances 0.000 description 1
- 235000010332 potassium propionate Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 238000006462 rearrangement reaction Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Landscapes
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
æ¬çºæã¯ãã©ãã³èªå°äœã詳ããã¯äžè¬åŒ
ïŒïŒ ãåŒäžR1ã¯æ°Žé žåºåã¯äœçŽã¢ã«ã³ãã·åºãã
R2ã¯ççŽ æ°ïŒã14ã®ã¢ã«ã³ãã·åºããR3ã¯äœçŽ
ã¢ã«ã³ãã·åºã瀺ãããŸãR4ã¯æ°Žé žåºãççŽ æ°
ïŒã10ã®ã¢ã«ã«ãã€ã«ãªãã·åºãã·ã¯ãã¢ã«ãã«
ã«ã«ããã«ãªãã·åºããã³ãŸã€ã«ãªãã·åºãäœçŽ
ã¢ã«ã³ãã·äœçŽã¢ã«ã³ãã·åºåã¯ããšãã«äœçŽã¢
ã«ã³ãã·åºã瀺ãããŸãïœã¯ïŒãïŒã®æŽæ°ã瀺
ããã§è¡šãããããã©ãã³èªå°äœã«é¢ããã äžèšäžè¬åŒïŒïŒã§è¡šããããæ¬çºæã®ååç©
ã¯ããã€ã³ããªãšã³ã®çåæãã€ããã©ãã¢ã©ã
ãã³é žïŒâãªããã·ã²ããŒãŒïŒä»¥äžïŒâãªããã·
ã²ããŒãŒãšç¥ãïŒãé¡èã«é»å®³ããã¢ã©ããã³é ž
ïŒâãªããã·ã²ããŒãŒé»å®³å€ïŒä»¥äžãïŒâãªãã
ã·ã²ããŒãŒé»å®³å€ããšåŒã¶ïŒãšããŠæçšã§ããã åæ¯ãšã¯ãæ°ééææ§ã®é«ãæ£è ããæ°éã«å¯Ÿ
ããå€çããã®ã¢ã¬ã«ã²ã³ãéç¹ç°çåºæ¿ïŒå¯
å·ã也ç¥ãªã©ïŒã«ãã€ãŠè¡ç®¡ééæ§äº¢é²ãæ°ç®¡æ¯
å¹³æ»çåçž®ãåæ³äº¢é²çãæ¹èµ·ããåŒåžå°é£ãã
ããçŸç ã§ãããçŸåšã該åæ¯ã®æ²»çæ³ãšããŠã¯
è¬ç©çæ³ã転å°çæ³ãæžæäœçæ³ãå¿ççæ³ãªã©
ã®å€è§çæ²»çæ³ãè¡ãªãããŠããããæªã å åãª
æ²»çå¹æãå¥ããæ¹æ³ã¯ç¢ºç«ãããŠããªãã çŸåšæåæ¯è¬ãšããŠãã䜿çšãããŠãããã®ãš
ããŠã¯ãããŒã¿å容äœåºæ¿å€ãããµã³ãã³å€ãã¹
ããã€ãå€ãæãã¹ã¿ãã³å€ãååŠäŒéç©è³ªéé¢
æå¶å€ãªã©ãããããããå皮治çè¬ã®åæ¯ã«å¯Ÿ
ããäœçšã¡ã«ããºã ã¯å°æ確ã§ã¯ãªãããäžè¬ã«
以äžã®åŠãã§ãããšèšãããŠãããå³ã¡ãããŒã¿
å容äœåºæ¿å€ã¯ã¢ããã«ãµã€ã¯ã©ãŒãŒã®é µçŽ 掻æ§
ãé«ããATPã第äºæ¬¡æ å ±äŒéç©è³ªã®ïœâAMP
ã«å€åããããããµã³ãã³å€ã¯ïœâAMPãæ å ±
äŒéäœçšã®ãªãïŒâAMPã«å€åããããã¹ããž
ãšã¹ãã©ãŒãŒã®æŽ»æ§é»å®³äœçšã«ãã€ãŠæ°ç®¡æ¯ãæ¡
匵ããããæãã¹ã¿ãã³å€ã¯ãã¹ã¿ãã³H1å容
äœã«ãããŠãã¹ã¿ãã³ãšæ®æããããšã«ãããè¡
管ééæ§äº¢é²ã«ããæ°ç®¡æ¯ç²èã®æµ®è «ãè «è¹ã軜
æžãããååŠäŒéç©è³ªéé¢æå¶å€ã¯ããã¹ã现è
ããã®ååŠäŒéç©è³ªã®éé¢ãæå¶ããããšã«ãã€
ãŠåæ¯çºäœãæãããããããªããããçåçš®æ
åæ¯è¬ã¯åã äžé·äžçããããããããå°å åãª
æ²»çå¹æãå¥ãåŸãªãçŸç¶ã§ããã ãŸããåæ¯æ²»çã«é¢ããç 究ãé²ãã«ã€ããŠã
åæ¯ã®äž»èŠãªç å ç©è³ªãšèããããŠããé åå¿æ§
ã¢ããã€ã©ãã·ãŒç©è³ªïŒSlow reacting
substance of anaphylaxis以äžãSRSâããš
ç¥ãïŒãåå®ããããã€ã³ããªãšã³ãçºèŠããã
ã«è³ã€ããR.C.Murphy et alïŒProc.Nat.Acad.
Sci.USAïŒ76ïŒ4275ïŒ1979ïŒB.Sanmelsson.ïŒ
Science220ïŒ568ïŒ1983ïŒå±±æ¬å°äžãæ¥æ¬èšåºã
41ïŒ1934ïŒ1983ïŒåç §ãã ãã®SRSâã«ããã°ãåæ¯ã®äž»çç¶ã§ããè¡
管ééæ§äº¢é²ã«ããæ°ç®¡æ¯ç²èã®æµ®è «ãšè «è¹åã³
æ°ç®¡æ¯å¹³æ»çåçž®ãªã©ãã¿ããããA.C.
Peatfield et al.ïŒBr.J.Pharmacol.ïŒ77ïŒ391
ïŒ1982ïŒãM.C.Holroyde et al.ïŒAgents
ActionsïŒ11ïŒ573ïŒ1981ïŒãZ.Marom et al.ïŒ
Am.Rev.Respir Dis.ïŒ126ïŒ449ïŒ1982ïŒåç §ãã æ¬çºæè ãã¯ãå ŒãŠããäžèšåæ¯ã®æ²»çåã³ã
ã®ããã®æåæ¯è¬ã«ã€ããéæç 究ãéããŠãã
ãããã®éçšã«ãããŠäžèšSRSâãã¢ã©ããã³
é žããåæããããã®çåæã«ïŒâãªããã·ã²ã
ãŒãŒãé¢äžããŠããã該ïŒâãªããã·ã²ããŒãŒã®
掻æ§ãé»å®³ããããšã«ãã€ãŠSRSâã®çæãæ
å¶ãããããã«èµ·å ããŠåæ¯ã®æ²»çãå¯èœãšãªã
ãšã®çæ³ãããäžèšïŒâãªããã·ã²ããŒãŒé»å®³äœ
çšãæããç©è³ªã«ã€ãç 究ãé²ããããã®çµæã
äžèšäžè¬åŒïŒïŒã§è¡šããããããçš®ã®ãã©ãã³
èªå°äœããææã®ïŒâãªããã·ã²ããŒãŒé»å®³å€ãš
ããŠæçšã§ããããã®å©çšã«ããã°ã¢ã©ããã³é ž
ããã®SRSâã®çæãæå¶ããã該SRSâã®
çæã«èµ·å ããåçš®ã®çŸæ£äŸãã°åæ¯ãççãã¢
ã¬ã«ã®ãŒçãäºé²åã³æ²»çã§ãããšããæ°ããç¥
èŠãåŸãã æ¬çºæã¯äžèšç¥èŠã«åºã¥ããŠå®æããããã®ã§
ãããåèšäžè¬åŒïŒïŒã§è¡šãããããã©ãã³èª
å°äœåã³ãã®å¡©ããã®èŠæšãšãããã®ã§ããã æ¬çºæã«ä¿ãäžèšãã©ãã³èªå°äœãè¡šããäžè¬
åŒïŒïŒã«ãããŠR1ãŸãã¯R3ã§å®çŸ©ãããäœçŽ
ã¢ã«ã³ãã·åºãšããŠã¯ãäŸãã°ã¡ããã·åºããšã
ãã·åºãããããã·åºãã€ãœããããã·åºããã
ãã·åºããã³ãã«ãªãã·åºãããã·ã«ãªãã·åºç
ã®ççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºãäŸç€ºåºæ¥ãã
R2ã§ç€ºãããççŽ æ°ïŒã14ã®ã¢ã«ã³ãã·åºãšã
ãŠã¯ãããã·åºãïœâãããã·åºããã³ãã«ãªã
ã·åºãããã·ã«ãªãã·åºããããã«ãªãã·åºããª
ã¯ãã«ãªãã·åºãããã«ãªãã·åºããã«ãã«ãªã
ã·åºããŠã³ãã«ãã«ãªãã·åºãããã«ãã«ãªãã·
åºãäŸç€ºåºæ¥ãããŸãR4ã§å®çŸ©ãããççŽ æ°ïŒ
ã10ã®ã¢ã«ã«ãã€ã«ãªãã·åºãšããŠã¯ãäŸãã°ã¢
ã»ããã·åºãããããªãã«ãªãã·åºããããªã«ãª
ãã·åºãtertâãããªã«ãªãã·åºããã³ã¿ãã€ã«
ãªãã·åºããããµãã€ã«ãªãã·åºãããã¿ãã€ã«
ãªãã·åºããªã¯ã¿ãã€ã«ãªãã·åºããã«ãã€ã«ãª
ãã·åºããã«ãã«ãªãã·åºçãäŸç€ºåºæ¥ãããŸã
ã·ã¯ãã¢ã«ãã«ã«ã«ããã«ãªãã·åºãšããŠã¯ãã·
ã¯ããããã«ã«ã«ããã«ãªãã·åºãã·ã¯ãããã«
ã«ã«ããã«ãªãã·åºãã·ã¯ããã³ãã«ã«ã«ããã«
ãªãã·åºãã·ã¯ãããã·ã«ã«ã«ããã«ãªãã·åºã
ã·ã¯ãããã·ã«ã«ã«ããã«ãªãã·åºãã·ã¯ããã
ãã«ã«ã«ããã«ãªãã·åºãã·ã¯ããªã¯ãã«ã«ã«ã
ãã«ãªãã·åºçã®ççŽ æ°ïŒãïŒã®ã·ã¯ãã¢ã«ãã«
åºãäŸç€ºã§ããã äœçŽã¢ã«ã³ãã·äœçŽã¢ã«ã³ãã·åºãšããŠã¯ãã¡
ããã·ã¡ããã·åºããšããã·ã¡ããã·åºãããã
ãã·ã¡ããã·åºããããã·ã¡ããã·åºããã³ãã«
ãªãã·ã¡ããã·åºãããã·ã«ãªãã·ã¡ããã·åºã
ïŒâã¡ããã·ãšããã·åºãïŒâã¡ããã·ãšããã·
åºãïŒâããããã·ãšããã·åºãïŒâããã·ã«ãª
ãã·ãšããã·åºãïŒâã¡ããã·ããããã·åºãïŒ
âã¡ããã·ããããã·åºãïŒâãããã·ãããã
ã·åºãïŒâãã³ãã«ãªãã·ããããã·åºãïŒâã¡
ããã·ãããã·åºãïŒâããããã·ãããã·åºã
ïŒâããã·ã«ãªãã·ãããã·åºãïŒâãšããã·ã
ã³ãã«ãªãã·åºãïŒâããããã·ãã³ãã«ãªãã·
åºãïŒâã¡ããã·ããã·ã«ãªãã·åºãïŒâãšãã
ã·ããã·ã«ãªãã·åºãïŒâãã³ãã«ãªãã·ããã·
ã«ãªãã·åºçã®ççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºã眮
æåºãšããŠæããççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºã
äŸç€ºããããšãã§ããã ããšãã«äœçŽã¢ã«ã³ãã·åºãšããŠã¯ãã³ãžã«ãª
ãã·ãαâããšããã«ãªãã·ãβâããšããã«ãª
ãã·ãïŒâããšãã«ããããã·ãïŒâããšãã«ã
ããã·ãïŒâããšãã«ãã³ãã«ãªãã·ãïŒâããš
ãã«ããã·ã«ãªãã·ãïŒïŒïŒâãžã¡ãã«ãã³ãžã«
ãªãã·çã®ã¢ã«ã³ãã·éšåã®ççŽ æ°ãïŒãïŒã®ã
ãšãã«äœçŽã¢ã«ã³ãã·ãäŸç€ºåºæ¥ãã äžèšäžè¬åŒïŒïŒã®ååç©ã¯åçš®ã®æ¹æ³ã§åæ
å¯èœã§ããããäŸãã°äžèšåå¿è¡çšåŒâïŒåã¯â
ïŒã«ç€ºãæ¹æ³ã«ãã容æã«è£œé ããããšãåºæ¥
ãã ãåå¿è¡çšåŒâã ãåŒäžR1â²ã¯äœçŽã¢ã«ã³ãã·åºãR2ïŒR3ã¯åèš
ã«åãã§ãããR4â²ã¯ççŽ æ°ïŒã10ã®ã¢ã«ã«ãã€
ã«ãªãã·åºãã·ã¯ãã¢ã«ãã«ã«ã«ããã«ãªãã·
åºããã³ãŸã€ã«ãªãã·åºãäœçŽã¢ã«ã³ãã·äœçŽã¢
ã«ã³ãã·åºåã¯ããšãã«äœçŽã¢ã«ã³ãã·åºã瀺
ãããŸãã¯ããã²ã³ååã瀺ãã äžèšã«ãããŠãå ¬ç¥ã®äžè¬åŒïŒïŒã§è¡šããã
ãååç©ãšäžè¬åŒïŒïŒã§è¡šããããå ¬ç¥ååç©
ãšã®ãšã¹ãã«ååå¿ã¯ãç¡æº¶åªåã¯éåžžã®äžæŽ»æ§
溶åªäžãïŒã200âã奜ãŸããã¯80âã130âã®æž©
床æ¡ä»¶äžã«ãïŒãïŒæéçšåºŠã§å®çµãããäžæŽ»æ§
溶åªãšããŠã¯äŸãã°ãã³ãŒã³ããã«ãšã³ããã·ã¬
ã³çã®è³éŠæçåæ°ŽçŽ é¡ïŒãããµã³ãããã¿ã³ç
ã®èèªæçåæ°ŽçŽ é¡ïŒãžãªããµã³ãããã©ããã
ãã©ã³ããšãã«ãšãŒãã«çã®ãšãŒãã«é¡ïŒããªãž
ã³ãïŒïŒ®âãžã¡ãã«ã¢ããªã³çã®ç¬¬ïŒçŽã¢ãã³
é¡ïŒãžã¡ãã«ãã«ã ã¢ããããžã¡ãã«ã¹ã«ããã·
ãçã䜿çšã§ãããäžèšåå¿ã¯ããæå©ã«ã¯å¡©åº
æ§ååç©ãè±ããã²ã³åæ°ŽçŽ å€ãšããŠçšããŠè¡ãª
ãããã該塩åºæ§ååç©ãšããŠã¯äŸãã°ãããªãš
ãã«ã¢ãã³ãããªãããã«ã¢ãã³ãããªãžã³ãã
ããªã³ãïŒïŒ®âãžãšãã«ã¢ããªã³çã®ç¬¬ïŒçŽã¢
ãã³çãäŸç€ºã§ããããŸãäžèšã«ãããäžè¬åŒ
ïŒïŒã§è¡šããããååç©ãšäžè¬åŒïŒïŒã§è¡šã
ãããååç©ãšã®äœ¿çšå²åã¯ãéåžžåè ïŒã¢ã«ã«
察ããŠåŸè ãçã¢ã«ä»¥äžã奜ãŸããã¯ïŒã1.5ã¢
ã«ãšããã°ãããããããŠäžè¬åŒïŒïŒã§è¡šãã
ãããšã¹ãã«ãåŸãã äžè¬åŒïŒïŒã§è¡šãããããšã¹ãã«ã®è»¢ç§»åå¿
ã¯ãå¡©åºæ§ååç©ã®ååšäžãäžæŽ»æ§æº¶åªäžã宀枩
ã100âçšåºŠã§ïŒã10æéãèŠããŠè¡ãªãããã
ãã«ããååå 転移åå¿ïŒBakerâ
Venkataramanåå¿ïŒãè¡ãªããããå¡©åºæ§åå
ç©ãšããŠã¯äŸãã°ãæ°Žé žåã«ãªãŠã ãæ°Žé žåãã
ãªãŠã ãçé žã«ãªãŠã ããããªãŠã ã¢ããçãäŸ
瀺ã§ãããäžæŽ»æ§æº¶åªãšããŠã¯ãç¹ã«å¶éã¯ãªã
åºã䜿çšã§ãäŸãã°ãã³ãŒã³ããã«ãšã³ããã·ã¬
ã³çã®è³éŠæçåæ°ŽçŽ é¡ïŒãžãªããµã³ãããã©ã
ãããã©ã³ããžãšãã«ãšãŒãã«çã®ãšãŒãã«é¡ïŒ
ãããµã³ãããã¿ã³çã®èèªæçåæ°ŽçŽ é¡ïŒããª
ãžã³ããã³ãªã³çã®ããªãžã³èªå°äœçãäŸç€ºã§ã
ããäžèšè»¢ç§»åå¿ã«ãããŠäžè¬åŒïŒïŒã®ååç©
ã«å¯Ÿããå¡©åºæ§ååç©ã®äœ¿çšå²åã¯ãéåžžåè ïŒ
ã¢ã«ã«å¯ŸããŠåŸè ãïŒã30ã¢ã«éçšåºŠãšããã°ã
ããããããŠäžè¬åŒïŒïŒã§è¡šãããããžã±ãã³
ååç©ãåŸãã äžèšã®ãžã±ãã³ååç©ïŒïŒã®éç°åå¿ã¯ãç¡
溶åªåã¯æº¶åªäžã觊åªã®ååšäžã«ã宀枩ã150â
ã®æž©åºŠæ¡ä»¶äžã«ãïŒã15æéçšåºŠã§è¡ãªãããã
溶åªãšããŠã¯äŸãã°è»é žãé ¢é žãããããªã³é žç
ã®ã«ã«ãã³é žé¡ïŒãã³ãŒã³ããã«ãšã³ããã·ã¬ã³
çã®è³éŠæçåæ°ŽçŽ é¡ïŒãšãã«ãšãŒãã«ããžãªã
ãµã³ãããã©ããããã©ã³çã®ãšãŒãã«é¡ïŒã¡ã¿
ããŒã«ããšã¿ããŒã«çã®ã¢ã«ã³ãŒã«é¡çãäŸç€ºã§
ããã觊åªãšããŠã¯äŸãã°é ¢é žãããªãŠã ãé ¢é ž
ã«ãªãŠã ãããããªã³é žãããªãŠã ãããããªã³
é žã«ãªãŠã çãäŸç€ºã§ãããããããŠäžè¬åŒïŒ
ïœïŒã§è¡šãããããã©ãã³èªå°äœãåŸãã ãåå¿è¡çšåŒâã ãåŒäžR1â²ïŒR2ãR3ïŒR4â²åã³ïœã¯åèšã«åãã äžèšã«ãããŠäžè¬åŒïŒïŒã§è¡šããããååç©
ãšäžè¬åŒïŒïŒã§è¡šãããååç©ãšã®ã¢ã«ããŒã«
çž®ååå¿ã¯ãç¡æº¶åªåã¯éåžžã®äžæŽ»æ§æº¶åªäžãé ž
åã¯å¡©åºæ§è§Šåªã®ååšäžã«ãïŒã100âã®æž©åºŠæ¡
件äžã10ã72æéçšåºŠã§è¡ãªããããäžæŽ»æ§æº¶åª
ãšããŠã¯ãžã¡ãã«ãã«ã ã¢ããããžãšãã«ãã«ã
ã¢ããçã®ã¢ããé¡ïŒã¡ã¿ããŒã«ããšã¿ããŒã«ç
ã®ã¢ã«ã³ãŒã«é¡ïŒãžãšãã«ãšãŒãã«çã®ãšãŒãã«
é¡çãäŸç€ºã§ããã觊åªãšããŠã¯å¡©é žãç¡«é žãç
ã®ç¡æ©é žïŒé ¢é žãããããªã³é žçã®ææ©é žé¡ãªã©
ã®é žæ§è§ŠåªãäŸç€ºã§ããããŸã觊åªãšããŠã¯æ°Žé ž
åã«ãªãŠã ãæ°Žé žåãããªãŠã ããããªãžã³çã®
å¡©åºæ§è§Šåªãã䜿çšããããšãã§ãããäžèšã«ã
ããŠååç©ïŒïŒã«å¯Ÿããååç©ïŒïŒã®äœ¿çšå²
åã¯ç¹ã«å¶éã¯ãªããéåžžåè ïŒã¢ã«ã«å¯ŸããŠåŸ
è ãïŒã1.5ã¢ã«é䜿çšããã®ãããããŸãäžè¬
åŒïŒïŒã®ååç©ïŒã¢ã«ã«å¯Ÿãã觊åªã®äœ¿çšéã¯
ïŒã10åã¢ã«éãšããã°ãããããããŠäžè¬åŒ
ïŒïŒã§è¡šããããååç©ãåŸãã ãã®ååç©ïŒïŒã®éç°åå¿ã¯ã觊åªã®ååš
äžãäžæŽ»æ§æº¶åªäžã§ãïŒã150âã®æž©åºŠæ¡ä»¶äžã§ã
ïŒã10æéçšåºŠãèŠããŠè¡ãªããããããã§è§Šåª
ãšããŠã¯äŸãã°äºé žåã»ã¬ã³ãäºé žåã€ãªãŠã
ïŒïŒïŒâãžã¯ããâïŒïŒïŒâãžã·ã¢ãâïŒïŒïŒâ
ãã³ãŸããã³çãäŸç€ºã§ããäžæŽ»æ§æº¶åªãšããŠã¯
äŸãã°ã¡ãã«ã¢ã«ã³ãŒã«ããšãã«ã¢ã«ã³ãŒã«ãã€
ãœã¢ãã«ã¢ã«ã³ãŒã«çã®ã¢ã«ã³ãŒã«é¡ïŒãšãã«ãš
ãŒãã«ããžãªããµã³ãããã©ããããã©ã³çã®ãš
ãŒãã«é¡ïŒé ¢é žãšãã«ãé ¢é žã¡ãã«çã®ãšã¹ãã«
é¡ãäŸç€ºã§ãããäžèšåå¿ã«ãããŠååç©ïŒïŒ
ïŒã¢ã«ã«å¯Ÿãã觊åªã®äœ¿çšéã¯ãïŒã10ã¢ã«éçš
床ãšããã®ã奜ãŸãããããããŠäžè¬åŒïŒïœïŒ
ã§è¡šããããååç©ãåŸãã ãŸãäžè¬åŒïŒïŒäžR1ïŒR4ã®å°ããšãïŒçš®ã
æ°Žé žåºã瀺ãååç©ã¯äžèšåå¿è¡çšåŒã«ç€ºãåå¿
ã«ããåŸãããååç©ãR1â²ïŒïŒR4â²ïŒoã®å°ããšã
ïŒçš®ãäœçŽã¢ã«ã³ãã·åºãäœçŽã¢ã«ã³ãã·äœçŽã¢
ã«ã³ãã·åºãããšãã«äœçŽã¢ã«ã³ãã·åºãççŽ æ°
ïŒã10ã®ã¢ã«ã«ãã€ã«ãªãã·åºããã³ãŸã€ã«ãªã
ã·åºåã¯ã·ã¯ãã¢ã«ãã«ã«ã«ããã«ãªãã·åºãã
è±ã¢ã«ãã«åïŒè±ã¢ã«ã³ãã·ã¢ã«ãã«åãè±ããš
ãã«ã¢ã«ãã«åãå«ãïŒãè±ãã³ãžã«ååã³ïŒå
ã¯è±ã¢ã·ã«ååå¿ãããããšã«ããååŸåºæ¥ãã è±ãã³ãžã«ååå¿ã¯äžè¬åŒïŒïœïŒã§è¡šããã
ãååç©ãããã®çœ®æåºäžã«Î±âããšãã«äœçŽã¢
ã«ã³ãã·åºãå«ãå Žåã«ã該ååç©ã觊åªã®ååš
äžãäžæŽ»æ§æº¶åªäžãâ30ã100âã®æž©åºŠæ¡ä»¶äžã«ã
ïŒãïŒæéçšåºŠãèŠããŠæ°ŽçŽ åå解åå¿ãããã
ãšã«ããè¡ãªãããããã«ãã察å¿ããæ°Žé žåºã
æãããã©ãã³èªå°äœãååŸã§ãããããã§è§Šåª
ãšããŠã¯äŸãã°ãã©ãžãŠã âççŽ ãçœéâççŽ ã
ããã±ã«ãéãã³ãã«ãçã®éå±ååç©ãäŸç€ºã§
ãããäžæŽ»æ§æº¶åªãšããŠã¯ç¹ã«å¶éã¯ãªãäŸãã°
é ¢é žãšãã«ãé ¢é žã¡ãã«çã®ãšã¹ãã«é¡ïŒã¡ã¿ã
ãŒã«ããšã¿ããŒã«çã®ã¢ã«ã³ãŒã«é¡çãåºã䜿çš
ã§ãããäžèšåå¿åŒã«ãããäžè¬åŒïŒïœïŒã®å
åç©ã«å¯Ÿãã觊åªã®äœ¿çšå²åã¯éåžžåè ïŒéééš
ã«å¯ŸããŠåŸè ã0.01ã0.1éééšçšåºŠãšããã°ã
ãã è±ã¢ã«ãã«ååå¿ïŒè±ã¢ã«ã³ãã·ã¢ã«ãã«åå
å¿åã³è±ããšãã«ã¢ã«ãã«åãå«ãïŒã¯ãäžè¬åŒ
ïŒïœïŒã§è¡šããããååç©ããã®çœ®æåºäžã«ã
äœçŽã¢ã«ã³ãã·åºãããšãã«äœçŽã¢ã«ã³ãã·åºå
ã¯ïŒåã³äœçŽã¢ã«ã³ãã·äœçŽã¢ã«ã³ãã·åºãå«ã
å Žåã«ã該ååç©ãé žã®ååšäžãäžæŽ»æ§æº¶åªäžã
奜ãŸããã¯ç¡æ°Žæº¶åªã䜿çšããŠãâ30ã100âã®æž©
床æ¡ä»¶äžã«ïŒãïŒæéçšåºŠãèŠããŠåå¿ãããã
ãšã«ããè¡ãªãããããã«ãã察å¿ããæ°Žé žåºã
æãããã©ãã³èªå°äœãååŸããããšãã§ããã
ããã§é žãšããŠã¯äŸãã°ç¡æ°Žå¡©åã¢ã«ãããŠã ã
å¡©åã¹ãºãããåããŠçŽ ãå¡©åäºéãèåæ°ŽçŽ ãª
ã©ãäŸç€ºã§ããäžæŽ»æ§æº¶åªãšããŠã¯äŸãã°ããã
ãã³ãŒã³ããã«ãšã³ããã³ãŒã³çã®è³éŠæçåæ°Ž
çŽ ïŒãããµã³ããªã¯ã¿ã³çã®é£œåçåæ°ŽçŽ ïŒã¢ã»
ããããªã«çãäŸç€ºã§ãããäžèšåå¿ã«ãããäž
è¬åŒïŒïœïŒã®ååç©ã«å¯Ÿãã觊åªã®äœ¿çšå²åãš
ããŠã¯ãéåžžåè ïŒã¢ã«ã«å¯ŸããŠåŸè ãïŒã10ã¢
ã«éçšåºŠãšããã°ããã è±ã¢ã·ã«ååå¿ã¯äžè¬åŒïŒïœïŒã§è¡šãããã
ååç©ããã®çœ®æåºã«ççŽ æ°ïŒã10ã®ã¢ã«ã«ãã€
ã«ãªãã·åºãã·ã¯ãã¢ã«ãã«ã«ã«ããã«ãªãã·
åºããã³ãŸã€ã«ãªãã·åºãå«ãå Žåã«ã該ååç©
ãéåžžäžè¬çã«åºãè¡ãªããããšã¹ãã«ã®å æ°Žå
解åå¿ãšåæ§ã«ããŠå®æœåºæ¥ãã ãã®è±ã¢ã·ã«åã¯é žåã¯ã¢ã«ã«ãªè§Šåªã®ååš
äžãäžæŽ»æ§æº¶åªäžãïŒã100âã®æž©åºŠæ¡ä»¶äžã«ã
ïŒãïŒæéçšåºŠãèŠããŠè¡ãªãããã觊åªãšããŠ
ã¯äŸãã°å¡©é žãç¡«é žãå¡©åã¢ã«ãããŠã çã®ç¡æ©
é žïŒé ¢é žãè»é žçã®ææ©é žïŒæ°Žé žåãããªãŠã ã
çé žãããªãŠã ãæ°Žé žåã«ãªãŠã çã®ç¡æ©å¡©åºïŒ
ã¢ã³ã¢ãã¢ãããªãšãã«ã¢ãã³çã®ææ©å¡©åºãªã©
ãæãããããäžæŽ»æ§æº¶åªãšããŠã¯æ°Žãã¡ãã«ã¢
ã«ã³ãŒã«ããšãã«ã¢ã«ã³ãŒã«çã®ã¢ã«ã³ãŒã«é¡ïŒ
é ¢é žãããããªã³é žçã®ã«ã«ãã³é žããšãã«ãšãŒ
ãã«çã®ãšãŒãã«é¡ããžã¡ãã«ãã«ã ã¢ãããã¢
ã»ãã¢ããçã®ã¢ããé¡ãæããããã ããããŠäžèšè±ãã³ãžã«åãè±ã¢ã«ãã«ååã³
è±ã¢ã·ã«ååå¿ã®å°ãªããšãïŒçš®ã®åå¿ãè¡ãªã
ããšã«ãããR1ïŒïŒR4ïŒoã®ããããå°ãªããšãïŒ
çš®ãæ°Žé žåºã§ããææã®äžè¬åŒïŒïŒã§è¡šããã
ããã©ãã³èªå°äœãååŸã§ããã åæ¬çºæã®ãã©ãã³èªå°äœïŒïŒã®ãã¡ïŒR4ïŒ
oã®ïŒã€ãççŽ æ°ïŒã10ã®ã¢ã«ã«ãã€ã«ãªãã·åºã
ã·ã¯ãã¢ã«ãã«ã«ã«ããã«ãªãã·åºãåã¯ãã³ãŸ
ã€ã«ãªãã·åºã§ããååç©ã¯ããŸãäžèšã§è£œé ã
ããïŒR4ïŒoã®å°ããšãïŒçš®ãæ°Žé žåºã§ããåå
ç©ãã¢ã·ã«ååå¿ãããããšã«ãã€ãŠãååŸãã
ããšãåºæ¥ãã該ã¢ã·ã«ååå¿ã¯ã¢ã·ã«åå€ãšã
ãŠäŸãã°ççŽ æ°ïŒã10ã®ã¢ã«ã«ã³é žãã©ã€ããã·
ã¯ãã¢ã«ãã«ã«ã«ãã³é žãã©ã€ããå®æ¯éŠé žãã©
ã€ãçã®é žãã©ã€ãåã¯ççŽ æ°ïŒã20ã®ã¢ã«ã«ã³
é žç¡æ°Žç©ãã·ã¯ãã¢ã«ãã«ã«ã«ãã³é žç¡æ°Žç©ãå®
æ¯éŠé žç¡æ°Žç©çã®é žç¡æ°Žç©ãçšããŠåžžæ³ã«åŸãè¡
ãªããããé žãã©ã€ããçšããåå¿ã¯ãäžæŽ»æ§æº¶
åªäžãå¿ èŠã§ããã°è±ããã²ã³åæ°ŽçŽ å€äŸãã°ã
ãªãšãã«ã¢ãã³ããžã€ãœãããã«ãšãã«ã¢ãã³ã
ãªãžã³ãïŒïŒ®âãžãšãã«ã¢ããªã³çã®ã¢ãã³é¡
ãçšããŠãâ50ã150âã®æž©åºŠç¯å²å ã§ãïŒã24æ
éçšåºŠãèŠããŠè¡ãªãããã é žç¡æ°Žç©ãçšããåå¿ã¯ãäžæŽ»æ§æº¶åªäžã宀枩
ã200âã®æž©åºŠç¯å²ã§ãïŒã10æéçšåºŠã§è¡ãªã
ãããäžèšååå¿ã«ãããäžæŽ»æ§æº¶åªãšããŠã¯ã
äŸãã°ããããã³ãŒã³ãå¡©åãã³ãŒã³çã®è³éŠæ
çåæ°ŽçŽ é¡ïŒããªãžã³ãïŒïŒ®âãžã¡ãã«ã¢ããª
ã³çã®ã¢ãã³é¡ïŒãšãã«ãšãŒãã«çã®ãšãŒãã«
é¡ïŒãžã¯ããã¡ã¿ã³ããžã¯ãããšã¿ã³ãã¯ããã
ã«ã çã®ããã²ã³åçåæ°ŽçŽ é¡ã䜿çšããããšã
ã§ããããŸãäžèšã«ãããäžè¬åŒïŒïŒã®ååç©
ã«å¯Ÿããã¢ã·ã«åå€ã®äœ¿çšå²åã¯ãåè ïŒã¢ã«ã«
察ããŠåŸè ãïŒã¢ã«ä»¥äžã奜ãŸããã¯ïŒãïŒã¢ã«
éãšããã®ãè¯ããããããŠäžè¬åŒïŒïŒã§è¡šã
ãããååç©äžïŒR4ïŒoã®å°ãªããšãïŒã€ãççŽ
æ°ïŒã10ã®ã¢ã«ã«ãã€ã«ãªãã·åºãã·ã¯ãã¢ã«ã
ã«ã«ã«ããã«ãªãã·åºåã¯ãã³ãŸã€ã«ãªãã·åºã§
ããååç©ãåŸãã æ¬çºæã®ãã©ãã³èªå°äœïŒïŒã®ãã¡R1ãäœ
çŽã¢ã«ã³ãã·åºã§ããååç©ãåã¯ïŒR4ïŒoã®å°
ããšãäžã€ãäœçŽã¢ã«ã³ãã·äœçŽã¢ã«ã³ãã·åºã§
ããååç©ã¯ããŸãåèšã§è£œé ãããR1ïŒïŒR4ïŒo
ã®å°ããšãïŒã€ãæ°Žé žåºã§ããååç©ãã¢ã«ãã«
ååã¯ã¢ã«ã³ãã·ã¢ã«ãã«åããããšã«ãã€ãŠã
補é ããããšãåºæ¥ãã 該ã¢ã«ãã«ååã³ã¢ã«ã³ãã·ã¢ã«ãã«ååå¿ã¯
該ã¢ã«ãã«ååå¿ã¯ã¢ã«ãã«åå€ãšããŠäŸãã°äœ
çŽã¢ã«ãã«ãã©ã€ããäœçŽã¢ã«ã³ãã·äœçŽã¢ã«ã
ã«ãã©ã€ãããžã¢ã«ãã«ç¡«é žããžã¢ãŸã¢ã«ã«ã³ç
ãçšããŠè¡ãªãããšãã§ãããäœçŽã¢ã«ãã«ãã©
ã€ãåã³äœçŽã¢ã«ã³ãã·äœçŽã¢ã«ãã«ãã©ã€ãã
çšããåå¿ã¯ãåèšã¢ã·ã«ååå¿ãšåæ§ã®æ¹æ³ã«
ãã€ãŠè¡ãªãããããžã¢ã«ãã«ç¡«é žãçšããåå¿
ã¯ãäžæŽ»æ§æº¶åªäžã«ãŠå®€æž©ã150âã«ãŠè¡ãªãã
ããããã§ãžã¢ã«ãã«ç¡«é žãšããŠã¯äŸãã°ãžã¡ã
ã«ç¡«é žããžãšãã«ç¡«é žçãäŸç€ºã§ãããäžæŽ»æ§æº¶
åªãšããŠã¯ãã³ãŒã³ããã«ãšã³çã®è³éŠæçåæ°Ž
çŽ é¡ïŒãšãã«ãšãŒãã«çã®ãšãŒãã«é¡ãäŸç€ºã§ã
ããæ¯ãããŠäžè¬åŒïŒïŒäžR1ãäœçŽã¢ã«ã³ã
ã·åºåã¯ïŒR4ïŒoã®å°ããšãïŒã€ãäœçŽã¢ã«ã³ã
ã·äœçŽã¢ã«ã³ãã·åºã§ããææã®ãã©ãã³èªå°äœ
ãååŸåºæ¥ãã äžèšããåçš®æ¹æ³ã«åŸãåŸããããã©ãã³èªå°
äœäžãR1ïŒïŒR4ïŒoã®å°ãªããšãïŒçš®ãæ°Žé žåºã§ã
ãååç©ã¯ããããäŸãã°æ°Žé žåãããªãŠã çã®
ã¢ã«ã«ãªã«ããåŠçããããšã«ããè¬ççã«èš±å®¹
ãããã¢ã«ã«ãªå¡©ãšããããšãã§ããããããå¡©
ã亊æ¬çºæã®æå¹æåãšããŠå©çšã§ããã äžèšå€«ã ã®å·¥çšã§ã®ç®çååç©ã¯ãéåžžã®åé¢
æ段ã«ãã容æã«åé¢ç²Ÿè£œããããšãã§ãããã
ãåé¢æ段ãšããŠã¯äŸãã°æº¶åªæœåºæ³ãåžéæ³ã
åçµæ¶æ³ãåžçã¯ãããã°ã©ãã€ãŒãã€ãªã³äº€æ
ã¯ãããã°ã©ãã€ãŒãååãµããã¯ãããã°ã©ã
ã€ãŒçãäŸç€ºã§ããã ããããŠåŸãããäžè¬åŒïŒïŒã§è¡šããããã
ã©ãã³èªå°äœåã³ãã®å¡©ã¯ãããããïŒâãªãã
ã·ã²ããŒãŒãé»å®³ããäœçšãæããŠããããŸãæ¯
æ§ãäœããå¯äœçšãå°ãªããïŒâãªããã·ã²ããŒ
ãŒé»å®³å€ãšããŠæ¥µããŠæçšã§ããããŸããããã¯
ãã®æããé¡èãªïŒâãªããã·ã²ããŒãŒé»å®³äœçš
ãå©çšããŠãåæ¯ãççãã¢ã¬ã«ã®ãŒçã®çç¶ã«
察ããäºé²è¬ä¹è³æ²»çè¬ãšããŠæçšã§ãããåæ¬
çºæååç©ã®ãã¡R4ãæ°Žé žåºä»¥å€ã®ãã®ã¯åèš
è¬çäœçšã®æç¶æéãé·ããšããç¹åŸŽãæããŠã
ãããŸãæ¬çºæååç©ã®R4ã®çœ®æäœçœ®ã¯ç¹ã«é
å®ãããåºãç¯å²ããé©å®éžæãããã第ïŒïŒïŒ
äœãç¹ã«å¥œãŸããã äžè¬åŒïŒïŒã®ååç©åã³ãã®å¡©ã¯ãéåžžäžè¬
çãªå»è¬è£œå€ã®åœ¢æ ã§çšããããã補å€ã¯é垞䜿
çšãããå å¡«å€ãå¢éå€ãçµåå€ãä»æ¹¿å€ã厩å£
å€ãè¡šé¢æŽ»æ§å€ãæ»æ²¢å€çã®åžéå€ãããã¯è³Šåœ¢
å€ãçšããŠèª¿è£œãããããã®å»è¬è£œå€ãšããŠã¯å
çš®ã®åœ¢æ ãæ²»çç®çã«å¿ããŠéžæã§ãããã®ä»£è¡š
çãªãã®ãšããŠé å€ãåŽé§å€ãäžžå€ãæ£å€ã液
å€ãæžæ¿å€ãä¹³å€ãé¡ç²å€ãã«ãã»ã«å€ãåå€ã
泚å°å€ïŒæ¶²å€ãæžæ¿å€çïŒçãæãããããé å€
ã®åœ¢æ ã«æ圢ããã«éããŠã¯ãæ äœãšããŠãã®å
éã§å ¬ç¥ã®ãã®ãåºã䜿çšã§ããäŸãã°ä¹³ç³ãçœ
ç³ãå¡©åãããªãŠã ããããŠç³ãå°¿çŽ ããã³ã
ã³ãçé žã«ã«ã·ãŠã ãã«ãªãªã³ãçµæ¶ã»ã«ããŒ
ã¹ãã±ã€é žçã®è³Šåœ¢å€ãæ°Žããšã¿ããŒã«ãããã
ããŒã«ãåã·ãããããããŠç³æ¶²ããã³ãã³æ¶²ã
ãŒã©ãã³æº¶æ¶²ãã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ãã»
ã©ãã¯ãã¡ãã«ã»ã«ããŒã¹ããªã³é žã«ãªãŠã ãã
ãªããã«ãããªãã³çã®çµåå€ã也ç¥ãã³ãã³ã
ã¢ã«ã®ã³é žãããªãŠã ãã«ã³ãã³æªãã©ããã©ã³
æªãçé žæ°ŽçŽ ãããªãŠã ãçé žã«ã«ã·ãŠã ãããª
ãªãã·ãšãã¬ã³ãœã«ãã¿ã³èèªé žãšã¹ãã«é¡ãã©
ãŠãªã«ç¡«é žãããªãŠã ãã¹ãã¢ãªã³é žã¢ãã°ãªã»
ãªãããã³ãã³ãä¹³ç³çã®åŽ©å£å€ãçœç³ãã¹ãã¢
ãªã³ãã«ã«ãªãã¿ãŒãæ°ŽçŽ æ·»å æ²¹çã®åŽ©å£æå¶
å€ã第ïŒçŽã¢ã³ã¢ããŠã å¡©åºãã©ãŠãªã«ç¡«é žãã
ãªãŠã çã®åžåä¿é²å€ãã°ãªã»ãªã³ããã³ãã³ç
ã®ä¿æ¹¿å€ããã³ãã³ãä¹³ç³ãã«ãªãªã³ããã³ãã
ã€ããã³ãã€ãç¶ã±ã€é žçã®åžçå€ã粟補ã¿ã«
ã¯ãã¹ãã¢ãªã³é žå¡©ãããŠé žæªãããªãšãã¬ã³ã°
ãªã³ãŒã«çã®æ»æ²¢å€çãäŸç€ºã§ãããããã«é å€
ã¯å¿ èŠã«å¿ãéåžžã®å€ç®ãæœããé å€ãäŸãã°ç³
è¡£é ããŒã©ãã³è¢«å é ãè žæº¶è¢«é ããã€ã«ã ã³ãŒ
ãã€ã³ã°é ãããã¯äºéé ãå€å±€é ãšããããšã
ã§ãããäžžå€ã®åœ¢æ ã«æ圢ããã«éããŠã¯ãæ äœ
ãšããŠåŸæ¥å ¬ç¥ã®ãã®ãåºã䜿çšã§ããäŸãã°ã
ããŠç³ãä¹³ç³ããã³ãã³ãã«ã«ãªèã硬åæ€ç©
æ²¹ãã«ãªãªã³ãã¿ã«ã¯çã®è³Šåœ¢å€ãã¢ã©ãã¢ãŽã
æªããã©ã¬ã³ãæªããŒã©ãã³ããšã¿ããŒã«çã®çµ
åå€ãã©ããã©ã³ã«ã³ãã³çã®åŽ©å£å€çãäŸç€ºã§
ãããåå€ã®åœ¢æ ã«æ圢ããã«éããŠã¯ãæ äœãš
ããŠåŸæ¥å ¬ç¥ã®ãã®ãåºã䜿çšã§ããäŸãã°ããª
ãšãã¬ã³ã°ãªã³ãŒã«ãã«ã«ãªèãé«çŽã¢ã«ã³ãŒ
ã«ãé«çŽã¢ã«ã³ãŒã«ã®ãšã¹ãã«é¡ããŒã©ãã³ãå
åæã°ãªã»ã©ã€ãçãæããããšãã§ããã泚å°
å€ãšããŠèª¿è£œãããå Žåã«ã¯ã液å€åã³æžæ¿å€ã¯
殺èããããã€è¡æ¶²ãšç匵ã§ããã®ã奜ãŸããã
ããã液å€ãä¹³å€åã³æžæ¿å€ã®åœ¢æ ã«æ圢ããã«
éããŠã¯ãåžéå€ãšããŠãã®åéã«ãããŠæ £çšã
ããŠãããã®ããã¹ãŠäœ¿çšã§ããäŸãã°æ°Žããšã
ã«ã¢ã«ã³ãŒã«ããããã¬ã³ã°ãªã³ãŒã«ããšããã·
åã€ãœã¹ãã¢ãªã«ã¢ã«ã³ãŒã«ãããªãªãã·åã€ãœ
ã¹ãã¢ãªã«ã¢ã«ã³ãŒã«ãããªãªãã·ãšãã¬ã³ãœã«
ãã¿ã³èèªé žãšã¹ãã«é¡çãæããããšãã§ã
ãããªãããã®å Žåç匵æ§ã®æº¶æ¶²ã調補ããã«å
åãªéã®é£å¡©ããããŠç³ãããã¯ã°ãªã»ãªã³ãå»
è¬è£œå€äžã«å«æããããŠãããããŸãéåžžã®æº¶è§£
è£å©å€ãç·©è¡å€ãç¡çåå€çãæ·»å ããŠãããã
æŽã«å¿ èŠã«å¿ããŠçè²å€ãä¿åå€ãéŠæã颚å³
å€ãçå³å€çãä»ã®å»è¬åãå»è¬è£œå€äžã«å«æã
ãããŠãããã ãŸãäžèšãã©ãã³èªå°äœåã³ãã®å¡©ãåŽé§å€ã®
圢æ ã«ããéã«ã¯ãåæ£å€åã³åŽå°å€ãšããŠãã®
åéã§å ¬ç¥ã®ãã®ãåºã䜿çšã§ããåæ£å€ãšããŠ
ã¯äŸãã°å€§è±ã¬ã·ãã³ãåµé»ã¬ã·ãã³çã®ã¬ã·ã
ã³é¡ããªã¬ã€ã³é žããªããŒã«é žããªãã¬ã³é žçã®
èèªé žããœã«ãã¿ã³ããªãªã¬ãŒãããœã«ãã¿ã³ã¢
ããªã¬ãŒãçã®ãœã«ãã¿ã³é¡çãäŸç€ºã§ããããŸ
ãåŽå°å€ãšããŠäŸãã°ãã¬ãªã³11ããã¬ãªã³12ã
ãã¬ãªã³114çã®éåžžäžçæ§æ¶²åã¬ã¹ãäŸç€ºã§ã
ãã äžè¬åŒïŒïŒã®ååç©åã¯ãã®å¡©ã®å»è¬è£œå€äž
ã«å«æãããã¹ãéãšããŠã¯ãç¹ã«éå®ãããåº
ç¯å²ã«é©å®éžæãããããéåžžå»è¬è£œå€äžïŒã70
ééïŒ ã奜ãŸããã¯ïŒã30ééïŒ ã§ããã äžèšå»è¬è£œå€ã®æäžæ¹æ³ã¯ç¹ã«å¶éã¯ãªããå
皮補å€åœ¢æ ãæ£è ã®å¹Žéœ¢ãæ§å¥ãã®ä»ã®æ¡ä»¶ãæ£
è ã®çšåºŠçã«å¿ããæ¹æ³ã§æäžããããäŸãã°é
å€ãäžžå€ã液å€ãæžæ¿å€ãä¹³å€ãé¡ç²å€åã³ã«ã
ã»ã«å€ã®å Žåã«ã¯çµå£æäžãããããŸã泚å°å€ã®
å Žåã«ã¯åç¬ã§ãããã¯ãããŠç³ãã¢ããé žçã®
éåžžã®è£æ¶²ãšæ··åããŠéèå æäžãããæŽã«ã¯å¿
èŠã«å¿ããŠåç¬ã§çèå ãç®å ãç®äžãããã¯è ¹
è å æäžããããåå€ã®å Žåã«ã¯çŽè žå æäžãã
ããååŽé§å€ã¯å£åã¯éŒ»ããåŽé§ããŠæ°ç®¡æ¯ãžæ
äžãããã æ¬çºæã®ïŒâãªããã·ã²ããŒãŒé»å®³å€ã®æäžé
ã¯çšæ³ãæ£è ã®å¹Žéœ¢ãæ§å¥ãã®ä»ã®æ¡ä»¶ãçŸæ£ã®
çšåºŠçã«ããé©å®éžæãããããéåžžæå¹æåã§
ããäžè¬åŒïŒïŒã®ååç©ã®éã¯ïŒæ¥åœãäœéïŒ
KgåœãçŽ0.005ã10mgã奜ãŸããã¯0.1ãïŒmgãšã
ãã®ãããã 以äžã«åèäŸãè¬çè©Šéšçµæåã³è£œå€äŸãæã
ãã åèäŸ ïŒ ïŒâããããã·âïŒâïœâããã·ã«ãªãã·â
ïŒïŒïŒâãžã¡ããã·ã¢ã»ãããšãã³7.2ïœãšïŒïŒ
ïŒâãžãã³ãžã«ãªãã·ãã³ãŸã€ã«ã¯ãã©ã€ã11ïœ
ãšãã也ç¥ããªãžã³15mlã«æº¶è§£ãã120âã§ïŒæ
éåå¿ãããããã®åå¿æº¶æ¶²ã宀枩ãŸã§å·åŽãã
æ°·âåžå¡©é žäžã«å ãããšãŒãã«æœåºããããšãŒã
ã«å±€ãæ°Žãçé žã«ãªãŠã 氎溶液ãæ°Žã§é 次æŽæµã
也ç¥ããããšãŒãã«ãæžå§çå»ããŠæ²¹ç¶ã®ïŒâ
ïŒ3â²ïŒ4â²âãžãã³ãžã«ãªãã·ïŒãã³ãŸã€ã«ãªãã·
âïŒâïœâããã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·
ã¢ã»ãããšãã³16ïœãåŸãã åèäŸ ïŒ åèšåèäŸïŒã§åŸãïŒâïŒ3â²ïŒ4â²âãžãã³ãžã«
ãªãã·ïŒãã³ãŸã€ã«ãªãã·âïŒâïœâããã·ã«ãª
ãã·âïŒïŒïŒâãžã¡ããã·ã¢ã»ãããšãã³16ïœã
也ç¥ããªãžã³30mlã«æº¶è§£ãã次ã«ç²æªæ°Žé žåã«ãª
ãŠã 15ïœãå ã60âã«å ç±ããæ¹æããïŒæéå
å¿ããããšãåå¿æº¶æ¶²ã¯ç²è¹ã«ãªãããã®åå¿æº¶
液ãåèšåèäŸïŒãšåæ§ã«æ°·âå¡©é žäžã«å ãé ¢é ž
ãšãã«ã§æœåºãããé ¢é žãšãã«å±€ãæ°Žãçé žã«ãª
ãŠã 氎溶液ãæ°Žã®é ã«æŽæµåŸã也ç¥ãããé ¢é žãš
ã¹ãã«ãçå»ããåŸãããé»è²æ²æ®¿ããé ¢é žãšã
ã«âã¡ã¿ããŒã«ã®æ··å溶åªã«ãŠåçµæ¶ããããšã«
ãããé»è²éç¶æ¶ã®ïŒâããããã·â3â²ïŒ4â²âãž
ãã³ãžã«ãªãã·âïŒâïœâããã·ã«ãªãã·âïŒïŒ
ïŒâãžã¡ããã·ãžãã³ãŸã€ã«ã¡ã¿ã³10ïœãåŸãã m.p.ïŒ96ã97â å®æœäŸ ïŒ ïŒâããããã·â3â²ïŒ4â²âãžãã³ãžã«ãªãã·â
ïŒâïœâããã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãž
ãã³ãŸã€ã«ã¡ã¿ã³10ïœãšé ¢é žãããªãŠã ïŒïœãš
ããæ°·é ¢é ž30mlã«æº¶è§£ããå ç±éæµãïŒæéè¡ãª
ããåå¿æº¶æ¶²ããšãŒãã«å«ææ°·æ°Žã«å ãæ¯ãšãã
ããæ²æ®¿ç©ãåããããã®æ²æ®¿ç©ããé ¢é žãšã
ã«ã«ãŠåçµæ¶ããŠ3â²ïŒ4â²âãžãã³ãžã«ãªãã·âïŒ
âïœâããã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©
ãã³7.5ïœïŒm.pïŒ132ã134âïŒãåŸãã å®æœäŸ ïŒ äžèšå®æœäŸïŒã§åŸãååç©ã®ïŒïœãã¡ã¿ããŒã«
âé ¢é žãšãã«ïŒïŒïŒïŒïŒ500ml溶液ãšã10ïŒ pdâ
C300mgã觊åªãšããŠè±ãã³ãžã«åããšã¿ããŒã«
ããåçµæ¶ããŠãç¡è²ããªãºã ç¶æ¶ã§ãã3â²ïŒ
4â²âãžããããã·âïŒâïœâããã·ã«ãªãã·â
ïŒïŒïŒâãžã¡ããã·ãã©ãã³2.6ïœãåŸãã m.p.ïŒ178ã180â å®æœäŸ ïŒ äžèšå®æœäŸïŒåã³å®æœäŸïŒãšåæ§ã«ããŠé©åœãª
åºçºåæãçšããŠä»¥äžã®ååç©ãåŸãã 3â²ïŒ4â²âãžããããã·âïŒâïœâããã«ãã«ãª
ãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ m.p.176ã178â æ·¡é»è²ããªãºã ç¶æ¶ å®æœäŸ ïŒ ç¡æ°Žå¡©åã¢ã«ãããŠã 0.69ïœïŒ0.002ã¢ã«ïŒã
也ç¥ããããã³ãŒã³70mlã«æº¶ããããã®æº¶æ¶²ãå·
åŽãããã®ã«3â²ïŒ4â²âãžããããã·âïŒâïœâã
ãã«ãã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³
1.0ïœïŒ0.002ã¢ã«ïŒã也ç¥ããããã³ãŒã³10mlã«
溶ããããã®ã滎äžãã滎äžåŸïŒæé60ã70âã«
ãŠæ¹æåå¿ãããããã®æº¶æ¶²ãæ°·100ïœãšå¡©é ž10
ïœãšã®æ··å液äžã«å ããåŸãå液ããŒãã«ãŠãã
ããã³ãŒã³ãåé¢ããæ°Žèžæ°èžçã«ãŠããããã³
ãŒã³ãçå»ãããæ®çæ²æ®¿ç©ãæ°Žã§æŽæµãããã
ãé ¢é žãšãã«âã¡ã¿ããŒã«ã§åçµæ¶ããŠãæ·¡é»è²
éç¶æ¶ã®ïŒïŒ3â²ïŒ4â²âããªããããã·âïŒâïœâ
ããã«ãã«ãªãã·âïŒâã¡ããã·ãã©ãã³0.89ïœ
ãåŸãã m.p.ïŒ248ã249â å®æœäŸ ïŒ ïŒïŒïŒâãžãã³ãžã«ãªãã·âïŒâãã€ãããã·
â5â²âïœâããã·ã«ãªãã·â4â²ïŒ6â²âãžã¡ããã·
ã«ã«ã³ã³2.98ïœïŒ0.005ã¢ã«ïŒãšäºé žåãŒã¬ã³3.33
ïœïŒ0.03ã¢ã«ïŒãšã粟補ããã€ãœã¢ãã«ã¢ã«ã³ãŒ
ã«50mlã«æº¶è§£ããïŒæéå ç±éæµãåå¿ãããã
ãã®åå¿æº¶æ¶²ããéå±ãŒã¬ã³ãå¥ãããšããã¬
ãŒã¿ãŒã«ãŠã»ãšãã©ã®æº¶åªãåãé€ããæ²æ®¿ç©ã
äžå€æŸçœ®ããåŸããã®æ²æ®¿ãé ¢é žãšãã«ã«ãŠåçµ
æ¶ããŠã3â²ïŒ4â²âãžãã³ãžã«ãªãã·âïŒâïœâã
ãã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³2.52
ïœãåŸãã m.p.ïŒ132ã134â å®æœäŸ ïŒ 3â²ïŒ4â²âãžãã³ãžã«ãªãã·âïŒâïœâããã·ã«
ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³1.36ïœ
ïŒ0.002ã¢ã«ïŒã10ïŒ æ¿å¡©é žå«æé ¢é ž20mlã«æº¶è§£
ãã50ã60âã§ïŒæéå ç±ãããåå¿æº¶æ¶²ãæ°Žã«
å ãæ²æ®¿ç©ãåŸãããã®æ²æ®¿ç©ãããšã¿ããŒã«ã
ãåçµæ¶ããŠã3â²ïŒ4â²âãžããããã·âïŒâïœâ
ããã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³
0.75ïœãåŸãã m.p.178ã180â ç¡è²ããªãºã ç¶æ¶ å®æœäŸ ïŒ 3â²ïŒ4â²âãžããããã·âïŒâïœâããã·ã«ãªã
ã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³2.0ïœåã³ç¡æ°Ž
é ¢é žïŒïœãããªãžã³ïŒmlã«æº¶è§£ãã100ã120âã§
ïŒæéå ç±ãããå·åŸåå¿æ··åç©ã«æ°Žãå ãæåº
æ¶ãåããããšã¿ããŒã«ããåçµæ¶ããŠç¡è²ã
ãªãºã æ¶ã®3â²ïŒ4â²âãžã¢ã»ããã·âïŒâïœâãã
ã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³2.0ïœ
ãåŸããïŒïŒ¡æ³ïŒ m.p.125ã125.5â å®æœäŸ ïŒ 3â²ïŒ4â²âãžããããã·âïŒâïœâããã·ã«ãªã
ã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³1.4ïœåã³ããª
ãšãã«ã¢ãã³1.2mlãç¡æ°Žãžã¯ããã¡ã¿ã³20mlã«
溶解ããæ°·å·ãæ¹æäžãïœâãããµãã€ã«ã¯ãã©
ã€ã1.1ïœã®ãžã¯ããã¡ã¿ã³10ml溶液ã滎äžããã
滎äžåŸå®€æž©ã§äžå€æ¹æãããåå¿æ¶²ãæ°ŽæŽã也ç¥
åŸã溶åªãçå»ãããæ®æž£ããšã¿ããŒã«âæ°Žãã
åçµæ¶ããŠãç¡è²ç²æªç¶ã®3â²ïŒ4â²âãžâïœâãã
ãµãã€ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³
1.2ïœãåŸããïŒïŒ¢æ³ïŒ m.p.81ã81.5â å®æœäŸïŒåã³ïŒãšåæ§ã«ããŠã以äžè¡šïŒã®åå
ç©ãåŸãã
ïŒïŒ ãåŒäžR1ã¯æ°Žé žåºåã¯äœçŽã¢ã«ã³ãã·åºãã
R2ã¯ççŽ æ°ïŒã14ã®ã¢ã«ã³ãã·åºããR3ã¯äœçŽ
ã¢ã«ã³ãã·åºã瀺ãããŸãR4ã¯æ°Žé žåºãççŽ æ°
ïŒã10ã®ã¢ã«ã«ãã€ã«ãªãã·åºãã·ã¯ãã¢ã«ãã«
ã«ã«ããã«ãªãã·åºããã³ãŸã€ã«ãªãã·åºãäœçŽ
ã¢ã«ã³ãã·äœçŽã¢ã«ã³ãã·åºåã¯ããšãã«äœçŽã¢
ã«ã³ãã·åºã瀺ãããŸãïœã¯ïŒãïŒã®æŽæ°ã瀺
ããã§è¡šãããããã©ãã³èªå°äœã«é¢ããã äžèšäžè¬åŒïŒïŒã§è¡šããããæ¬çºæã®ååç©
ã¯ããã€ã³ããªãšã³ã®çåæãã€ããã©ãã¢ã©ã
ãã³é žïŒâãªããã·ã²ããŒãŒïŒä»¥äžïŒâãªããã·
ã²ããŒãŒãšç¥ãïŒãé¡èã«é»å®³ããã¢ã©ããã³é ž
ïŒâãªããã·ã²ããŒãŒé»å®³å€ïŒä»¥äžãïŒâãªãã
ã·ã²ããŒãŒé»å®³å€ããšåŒã¶ïŒãšããŠæçšã§ããã åæ¯ãšã¯ãæ°ééææ§ã®é«ãæ£è ããæ°éã«å¯Ÿ
ããå€çããã®ã¢ã¬ã«ã²ã³ãéç¹ç°çåºæ¿ïŒå¯
å·ã也ç¥ãªã©ïŒã«ãã€ãŠè¡ç®¡ééæ§äº¢é²ãæ°ç®¡æ¯
å¹³æ»çåçž®ãåæ³äº¢é²çãæ¹èµ·ããåŒåžå°é£ãã
ããçŸç ã§ãããçŸåšã該åæ¯ã®æ²»çæ³ãšããŠã¯
è¬ç©çæ³ã転å°çæ³ãæžæäœçæ³ãå¿ççæ³ãªã©
ã®å€è§çæ²»çæ³ãè¡ãªãããŠããããæªã å åãª
æ²»çå¹æãå¥ããæ¹æ³ã¯ç¢ºç«ãããŠããªãã çŸåšæåæ¯è¬ãšããŠãã䜿çšãããŠãããã®ãš
ããŠã¯ãããŒã¿å容äœåºæ¿å€ãããµã³ãã³å€ãã¹
ããã€ãå€ãæãã¹ã¿ãã³å€ãååŠäŒéç©è³ªéé¢
æå¶å€ãªã©ãããããããå皮治çè¬ã®åæ¯ã«å¯Ÿ
ããäœçšã¡ã«ããºã ã¯å°æ確ã§ã¯ãªãããäžè¬ã«
以äžã®åŠãã§ãããšèšãããŠãããå³ã¡ãããŒã¿
å容äœåºæ¿å€ã¯ã¢ããã«ãµã€ã¯ã©ãŒãŒã®é µçŽ 掻æ§
ãé«ããATPã第äºæ¬¡æ å ±äŒéç©è³ªã®ïœâAMP
ã«å€åããããããµã³ãã³å€ã¯ïœâAMPãæ å ±
äŒéäœçšã®ãªãïŒâAMPã«å€åããããã¹ããž
ãšã¹ãã©ãŒãŒã®æŽ»æ§é»å®³äœçšã«ãã€ãŠæ°ç®¡æ¯ãæ¡
匵ããããæãã¹ã¿ãã³å€ã¯ãã¹ã¿ãã³H1å容
äœã«ãããŠãã¹ã¿ãã³ãšæ®æããããšã«ãããè¡
管ééæ§äº¢é²ã«ããæ°ç®¡æ¯ç²èã®æµ®è «ãè «è¹ã軜
æžãããååŠäŒéç©è³ªéé¢æå¶å€ã¯ããã¹ã现è
ããã®ååŠäŒéç©è³ªã®éé¢ãæå¶ããããšã«ãã€
ãŠåæ¯çºäœãæãããããããªããããçåçš®æ
åæ¯è¬ã¯åã äžé·äžçããããããããå°å åãª
æ²»çå¹æãå¥ãåŸãªãçŸç¶ã§ããã ãŸããåæ¯æ²»çã«é¢ããç 究ãé²ãã«ã€ããŠã
åæ¯ã®äž»èŠãªç å ç©è³ªãšèããããŠããé åå¿æ§
ã¢ããã€ã©ãã·ãŒç©è³ªïŒSlow reacting
substance of anaphylaxis以äžãSRSâããš
ç¥ãïŒãåå®ããããã€ã³ããªãšã³ãçºèŠããã
ã«è³ã€ããR.C.Murphy et alïŒProc.Nat.Acad.
Sci.USAïŒ76ïŒ4275ïŒ1979ïŒB.Sanmelsson.ïŒ
Science220ïŒ568ïŒ1983ïŒå±±æ¬å°äžãæ¥æ¬èšåºã
41ïŒ1934ïŒ1983ïŒåç §ãã ãã®SRSâã«ããã°ãåæ¯ã®äž»çç¶ã§ããè¡
管ééæ§äº¢é²ã«ããæ°ç®¡æ¯ç²èã®æµ®è «ãšè «è¹åã³
æ°ç®¡æ¯å¹³æ»çåçž®ãªã©ãã¿ããããA.C.
Peatfield et al.ïŒBr.J.Pharmacol.ïŒ77ïŒ391
ïŒ1982ïŒãM.C.Holroyde et al.ïŒAgents
ActionsïŒ11ïŒ573ïŒ1981ïŒãZ.Marom et al.ïŒ
Am.Rev.Respir Dis.ïŒ126ïŒ449ïŒ1982ïŒåç §ãã æ¬çºæè ãã¯ãå ŒãŠããäžèšåæ¯ã®æ²»çåã³ã
ã®ããã®æåæ¯è¬ã«ã€ããéæç 究ãéããŠãã
ãããã®éçšã«ãããŠäžèšSRSâãã¢ã©ããã³
é žããåæããããã®çåæã«ïŒâãªããã·ã²ã
ãŒãŒãé¢äžããŠããã該ïŒâãªããã·ã²ããŒãŒã®
掻æ§ãé»å®³ããããšã«ãã€ãŠSRSâã®çæãæ
å¶ãããããã«èµ·å ããŠåæ¯ã®æ²»çãå¯èœãšãªã
ãšã®çæ³ãããäžèšïŒâãªããã·ã²ããŒãŒé»å®³äœ
çšãæããç©è³ªã«ã€ãç 究ãé²ããããã®çµæã
äžèšäžè¬åŒïŒïŒã§è¡šããããããçš®ã®ãã©ãã³
èªå°äœããææã®ïŒâãªããã·ã²ããŒãŒé»å®³å€ãš
ããŠæçšã§ããããã®å©çšã«ããã°ã¢ã©ããã³é ž
ããã®SRSâã®çæãæå¶ããã該SRSâã®
çæã«èµ·å ããåçš®ã®çŸæ£äŸãã°åæ¯ãççãã¢
ã¬ã«ã®ãŒçãäºé²åã³æ²»çã§ãããšããæ°ããç¥
èŠãåŸãã æ¬çºæã¯äžèšç¥èŠã«åºã¥ããŠå®æããããã®ã§
ãããåèšäžè¬åŒïŒïŒã§è¡šãããããã©ãã³èª
å°äœåã³ãã®å¡©ããã®èŠæšãšãããã®ã§ããã æ¬çºæã«ä¿ãäžèšãã©ãã³èªå°äœãè¡šããäžè¬
åŒïŒïŒã«ãããŠR1ãŸãã¯R3ã§å®çŸ©ãããäœçŽ
ã¢ã«ã³ãã·åºãšããŠã¯ãäŸãã°ã¡ããã·åºããšã
ãã·åºãããããã·åºãã€ãœããããã·åºããã
ãã·åºããã³ãã«ãªãã·åºãããã·ã«ãªãã·åºç
ã®ççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºãäŸç€ºåºæ¥ãã
R2ã§ç€ºãããççŽ æ°ïŒã14ã®ã¢ã«ã³ãã·åºãšã
ãŠã¯ãããã·åºãïœâãããã·åºããã³ãã«ãªã
ã·åºãããã·ã«ãªãã·åºããããã«ãªãã·åºããª
ã¯ãã«ãªãã·åºãããã«ãªãã·åºããã«ãã«ãªã
ã·åºããŠã³ãã«ãã«ãªãã·åºãããã«ãã«ãªãã·
åºãäŸç€ºåºæ¥ãããŸãR4ã§å®çŸ©ãããççŽ æ°ïŒ
ã10ã®ã¢ã«ã«ãã€ã«ãªãã·åºãšããŠã¯ãäŸãã°ã¢
ã»ããã·åºãããããªãã«ãªãã·åºããããªã«ãª
ãã·åºãtertâãããªã«ãªãã·åºããã³ã¿ãã€ã«
ãªãã·åºããããµãã€ã«ãªãã·åºãããã¿ãã€ã«
ãªãã·åºããªã¯ã¿ãã€ã«ãªãã·åºããã«ãã€ã«ãª
ãã·åºããã«ãã«ãªãã·åºçãäŸç€ºåºæ¥ãããŸã
ã·ã¯ãã¢ã«ãã«ã«ã«ããã«ãªãã·åºãšããŠã¯ãã·
ã¯ããããã«ã«ã«ããã«ãªãã·åºãã·ã¯ãããã«
ã«ã«ããã«ãªãã·åºãã·ã¯ããã³ãã«ã«ã«ããã«
ãªãã·åºãã·ã¯ãããã·ã«ã«ã«ããã«ãªãã·åºã
ã·ã¯ãããã·ã«ã«ã«ããã«ãªãã·åºãã·ã¯ããã
ãã«ã«ã«ããã«ãªãã·åºãã·ã¯ããªã¯ãã«ã«ã«ã
ãã«ãªãã·åºçã®ççŽ æ°ïŒãïŒã®ã·ã¯ãã¢ã«ãã«
åºãäŸç€ºã§ããã äœçŽã¢ã«ã³ãã·äœçŽã¢ã«ã³ãã·åºãšããŠã¯ãã¡
ããã·ã¡ããã·åºããšããã·ã¡ããã·åºãããã
ãã·ã¡ããã·åºããããã·ã¡ããã·åºããã³ãã«
ãªãã·ã¡ããã·åºãããã·ã«ãªãã·ã¡ããã·åºã
ïŒâã¡ããã·ãšããã·åºãïŒâã¡ããã·ãšããã·
åºãïŒâããããã·ãšããã·åºãïŒâããã·ã«ãª
ãã·ãšããã·åºãïŒâã¡ããã·ããããã·åºãïŒ
âã¡ããã·ããããã·åºãïŒâãããã·ãããã
ã·åºãïŒâãã³ãã«ãªãã·ããããã·åºãïŒâã¡
ããã·ãããã·åºãïŒâããããã·ãããã·åºã
ïŒâããã·ã«ãªãã·ãããã·åºãïŒâãšããã·ã
ã³ãã«ãªãã·åºãïŒâããããã·ãã³ãã«ãªãã·
åºãïŒâã¡ããã·ããã·ã«ãªãã·åºãïŒâãšãã
ã·ããã·ã«ãªãã·åºãïŒâãã³ãã«ãªãã·ããã·
ã«ãªãã·åºçã®ççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºã眮
æåºãšããŠæããççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºã
äŸç€ºããããšãã§ããã ããšãã«äœçŽã¢ã«ã³ãã·åºãšããŠã¯ãã³ãžã«ãª
ãã·ãαâããšããã«ãªãã·ãβâããšããã«ãª
ãã·ãïŒâããšãã«ããããã·ãïŒâããšãã«ã
ããã·ãïŒâããšãã«ãã³ãã«ãªãã·ãïŒâããš
ãã«ããã·ã«ãªãã·ãïŒïŒïŒâãžã¡ãã«ãã³ãžã«
ãªãã·çã®ã¢ã«ã³ãã·éšåã®ççŽ æ°ãïŒãïŒã®ã
ãšãã«äœçŽã¢ã«ã³ãã·ãäŸç€ºåºæ¥ãã äžèšäžè¬åŒïŒïŒã®ååç©ã¯åçš®ã®æ¹æ³ã§åæ
å¯èœã§ããããäŸãã°äžèšåå¿è¡çšåŒâïŒåã¯â
ïŒã«ç€ºãæ¹æ³ã«ãã容æã«è£œé ããããšãåºæ¥
ãã ãåå¿è¡çšåŒâã ãåŒäžR1â²ã¯äœçŽã¢ã«ã³ãã·åºãR2ïŒR3ã¯åèš
ã«åãã§ãããR4â²ã¯ççŽ æ°ïŒã10ã®ã¢ã«ã«ãã€
ã«ãªãã·åºãã·ã¯ãã¢ã«ãã«ã«ã«ããã«ãªãã·
åºããã³ãŸã€ã«ãªãã·åºãäœçŽã¢ã«ã³ãã·äœçŽã¢
ã«ã³ãã·åºåã¯ããšãã«äœçŽã¢ã«ã³ãã·åºã瀺
ãããŸãã¯ããã²ã³ååã瀺ãã äžèšã«ãããŠãå ¬ç¥ã®äžè¬åŒïŒïŒã§è¡šããã
ãååç©ãšäžè¬åŒïŒïŒã§è¡šããããå ¬ç¥ååç©
ãšã®ãšã¹ãã«ååå¿ã¯ãç¡æº¶åªåã¯éåžžã®äžæŽ»æ§
溶åªäžãïŒã200âã奜ãŸããã¯80âã130âã®æž©
床æ¡ä»¶äžã«ãïŒãïŒæéçšåºŠã§å®çµãããäžæŽ»æ§
溶åªãšããŠã¯äŸãã°ãã³ãŒã³ããã«ãšã³ããã·ã¬
ã³çã®è³éŠæçåæ°ŽçŽ é¡ïŒãããµã³ãããã¿ã³ç
ã®èèªæçåæ°ŽçŽ é¡ïŒãžãªããµã³ãããã©ããã
ãã©ã³ããšãã«ãšãŒãã«çã®ãšãŒãã«é¡ïŒããªãž
ã³ãïŒïŒ®âãžã¡ãã«ã¢ããªã³çã®ç¬¬ïŒçŽã¢ãã³
é¡ïŒãžã¡ãã«ãã«ã ã¢ããããžã¡ãã«ã¹ã«ããã·
ãçã䜿çšã§ãããäžèšåå¿ã¯ããæå©ã«ã¯å¡©åº
æ§ååç©ãè±ããã²ã³åæ°ŽçŽ å€ãšããŠçšããŠè¡ãª
ãããã該塩åºæ§ååç©ãšããŠã¯äŸãã°ãããªãš
ãã«ã¢ãã³ãããªãããã«ã¢ãã³ãããªãžã³ãã
ããªã³ãïŒïŒ®âãžãšãã«ã¢ããªã³çã®ç¬¬ïŒçŽã¢
ãã³çãäŸç€ºã§ããããŸãäžèšã«ãããäžè¬åŒ
ïŒïŒã§è¡šããããååç©ãšäžè¬åŒïŒïŒã§è¡šã
ãããååç©ãšã®äœ¿çšå²åã¯ãéåžžåè ïŒã¢ã«ã«
察ããŠåŸè ãçã¢ã«ä»¥äžã奜ãŸããã¯ïŒã1.5ã¢
ã«ãšããã°ãããããããŠäžè¬åŒïŒïŒã§è¡šãã
ãããšã¹ãã«ãåŸãã äžè¬åŒïŒïŒã§è¡šãããããšã¹ãã«ã®è»¢ç§»åå¿
ã¯ãå¡©åºæ§ååç©ã®ååšäžãäžæŽ»æ§æº¶åªäžã宀枩
ã100âçšåºŠã§ïŒã10æéãèŠããŠè¡ãªãããã
ãã«ããååå 転移åå¿ïŒBakerâ
Venkataramanåå¿ïŒãè¡ãªããããå¡©åºæ§åå
ç©ãšããŠã¯äŸãã°ãæ°Žé žåã«ãªãŠã ãæ°Žé žåãã
ãªãŠã ãçé žã«ãªãŠã ããããªãŠã ã¢ããçãäŸ
瀺ã§ãããäžæŽ»æ§æº¶åªãšããŠã¯ãç¹ã«å¶éã¯ãªã
åºã䜿çšã§ãäŸãã°ãã³ãŒã³ããã«ãšã³ããã·ã¬
ã³çã®è³éŠæçåæ°ŽçŽ é¡ïŒãžãªããµã³ãããã©ã
ãããã©ã³ããžãšãã«ãšãŒãã«çã®ãšãŒãã«é¡ïŒ
ãããµã³ãããã¿ã³çã®èèªæçåæ°ŽçŽ é¡ïŒããª
ãžã³ããã³ãªã³çã®ããªãžã³èªå°äœçãäŸç€ºã§ã
ããäžèšè»¢ç§»åå¿ã«ãããŠäžè¬åŒïŒïŒã®ååç©
ã«å¯Ÿããå¡©åºæ§ååç©ã®äœ¿çšå²åã¯ãéåžžåè ïŒ
ã¢ã«ã«å¯ŸããŠåŸè ãïŒã30ã¢ã«éçšåºŠãšããã°ã
ããããããŠäžè¬åŒïŒïŒã§è¡šãããããžã±ãã³
ååç©ãåŸãã äžèšã®ãžã±ãã³ååç©ïŒïŒã®éç°åå¿ã¯ãç¡
溶åªåã¯æº¶åªäžã觊åªã®ååšäžã«ã宀枩ã150â
ã®æž©åºŠæ¡ä»¶äžã«ãïŒã15æéçšåºŠã§è¡ãªãããã
溶åªãšããŠã¯äŸãã°è»é žãé ¢é žãããããªã³é žç
ã®ã«ã«ãã³é žé¡ïŒãã³ãŒã³ããã«ãšã³ããã·ã¬ã³
çã®è³éŠæçåæ°ŽçŽ é¡ïŒãšãã«ãšãŒãã«ããžãªã
ãµã³ãããã©ããããã©ã³çã®ãšãŒãã«é¡ïŒã¡ã¿
ããŒã«ããšã¿ããŒã«çã®ã¢ã«ã³ãŒã«é¡çãäŸç€ºã§
ããã觊åªãšããŠã¯äŸãã°é ¢é žãããªãŠã ãé ¢é ž
ã«ãªãŠã ãããããªã³é žãããªãŠã ãããããªã³
é žã«ãªãŠã çãäŸç€ºã§ãããããããŠäžè¬åŒïŒ
ïœïŒã§è¡šãããããã©ãã³èªå°äœãåŸãã ãåå¿è¡çšåŒâã ãåŒäžR1â²ïŒR2ãR3ïŒR4â²åã³ïœã¯åèšã«åãã äžèšã«ãããŠäžè¬åŒïŒïŒã§è¡šããããååç©
ãšäžè¬åŒïŒïŒã§è¡šãããååç©ãšã®ã¢ã«ããŒã«
çž®ååå¿ã¯ãç¡æº¶åªåã¯éåžžã®äžæŽ»æ§æº¶åªäžãé ž
åã¯å¡©åºæ§è§Šåªã®ååšäžã«ãïŒã100âã®æž©åºŠæ¡
件äžã10ã72æéçšåºŠã§è¡ãªããããäžæŽ»æ§æº¶åª
ãšããŠã¯ãžã¡ãã«ãã«ã ã¢ããããžãšãã«ãã«ã
ã¢ããçã®ã¢ããé¡ïŒã¡ã¿ããŒã«ããšã¿ããŒã«ç
ã®ã¢ã«ã³ãŒã«é¡ïŒãžãšãã«ãšãŒãã«çã®ãšãŒãã«
é¡çãäŸç€ºã§ããã觊åªãšããŠã¯å¡©é žãç¡«é žãç
ã®ç¡æ©é žïŒé ¢é žãããããªã³é žçã®ææ©é žé¡ãªã©
ã®é žæ§è§ŠåªãäŸç€ºã§ããããŸã觊åªãšããŠã¯æ°Žé ž
åã«ãªãŠã ãæ°Žé žåãããªãŠã ããããªãžã³çã®
å¡©åºæ§è§Šåªãã䜿çšããããšãã§ãããäžèšã«ã
ããŠååç©ïŒïŒã«å¯Ÿããååç©ïŒïŒã®äœ¿çšå²
åã¯ç¹ã«å¶éã¯ãªããéåžžåè ïŒã¢ã«ã«å¯ŸããŠåŸ
è ãïŒã1.5ã¢ã«é䜿çšããã®ãããããŸãäžè¬
åŒïŒïŒã®ååç©ïŒã¢ã«ã«å¯Ÿãã觊åªã®äœ¿çšéã¯
ïŒã10åã¢ã«éãšããã°ãããããããŠäžè¬åŒ
ïŒïŒã§è¡šããããååç©ãåŸãã ãã®ååç©ïŒïŒã®éç°åå¿ã¯ã觊åªã®ååš
äžãäžæŽ»æ§æº¶åªäžã§ãïŒã150âã®æž©åºŠæ¡ä»¶äžã§ã
ïŒã10æéçšåºŠãèŠããŠè¡ãªããããããã§è§Šåª
ãšããŠã¯äŸãã°äºé žåã»ã¬ã³ãäºé žåã€ãªãŠã
ïŒïŒïŒâãžã¯ããâïŒïŒïŒâãžã·ã¢ãâïŒïŒïŒâ
ãã³ãŸããã³çãäŸç€ºã§ããäžæŽ»æ§æº¶åªãšããŠã¯
äŸãã°ã¡ãã«ã¢ã«ã³ãŒã«ããšãã«ã¢ã«ã³ãŒã«ãã€
ãœã¢ãã«ã¢ã«ã³ãŒã«çã®ã¢ã«ã³ãŒã«é¡ïŒãšãã«ãš
ãŒãã«ããžãªããµã³ãããã©ããããã©ã³çã®ãš
ãŒãã«é¡ïŒé ¢é žãšãã«ãé ¢é žã¡ãã«çã®ãšã¹ãã«
é¡ãäŸç€ºã§ãããäžèšåå¿ã«ãããŠååç©ïŒïŒ
ïŒã¢ã«ã«å¯Ÿãã觊åªã®äœ¿çšéã¯ãïŒã10ã¢ã«éçš
床ãšããã®ã奜ãŸãããããããŠäžè¬åŒïŒïœïŒ
ã§è¡šããããååç©ãåŸãã ãŸãäžè¬åŒïŒïŒäžR1ïŒR4ã®å°ããšãïŒçš®ã
æ°Žé žåºã瀺ãååç©ã¯äžèšåå¿è¡çšåŒã«ç€ºãåå¿
ã«ããåŸãããååç©ãR1â²ïŒïŒR4â²ïŒoã®å°ããšã
ïŒçš®ãäœçŽã¢ã«ã³ãã·åºãäœçŽã¢ã«ã³ãã·äœçŽã¢
ã«ã³ãã·åºãããšãã«äœçŽã¢ã«ã³ãã·åºãççŽ æ°
ïŒã10ã®ã¢ã«ã«ãã€ã«ãªãã·åºããã³ãŸã€ã«ãªã
ã·åºåã¯ã·ã¯ãã¢ã«ãã«ã«ã«ããã«ãªãã·åºãã
è±ã¢ã«ãã«åïŒè±ã¢ã«ã³ãã·ã¢ã«ãã«åãè±ããš
ãã«ã¢ã«ãã«åãå«ãïŒãè±ãã³ãžã«ååã³ïŒå
ã¯è±ã¢ã·ã«ååå¿ãããããšã«ããååŸåºæ¥ãã è±ãã³ãžã«ååå¿ã¯äžè¬åŒïŒïœïŒã§è¡šããã
ãååç©ãããã®çœ®æåºäžã«Î±âããšãã«äœçŽã¢
ã«ã³ãã·åºãå«ãå Žåã«ã該ååç©ã觊åªã®ååš
äžãäžæŽ»æ§æº¶åªäžãâ30ã100âã®æž©åºŠæ¡ä»¶äžã«ã
ïŒãïŒæéçšåºŠãèŠããŠæ°ŽçŽ åå解åå¿ãããã
ãšã«ããè¡ãªãããããã«ãã察å¿ããæ°Žé žåºã
æãããã©ãã³èªå°äœãååŸã§ãããããã§è§Šåª
ãšããŠã¯äŸãã°ãã©ãžãŠã âççŽ ãçœéâççŽ ã
ããã±ã«ãéãã³ãã«ãçã®éå±ååç©ãäŸç€ºã§
ãããäžæŽ»æ§æº¶åªãšããŠã¯ç¹ã«å¶éã¯ãªãäŸãã°
é ¢é žãšãã«ãé ¢é žã¡ãã«çã®ãšã¹ãã«é¡ïŒã¡ã¿ã
ãŒã«ããšã¿ããŒã«çã®ã¢ã«ã³ãŒã«é¡çãåºã䜿çš
ã§ãããäžèšåå¿åŒã«ãããäžè¬åŒïŒïœïŒã®å
åç©ã«å¯Ÿãã觊åªã®äœ¿çšå²åã¯éåžžåè ïŒéééš
ã«å¯ŸããŠåŸè ã0.01ã0.1éééšçšåºŠãšããã°ã
ãã è±ã¢ã«ãã«ååå¿ïŒè±ã¢ã«ã³ãã·ã¢ã«ãã«åå
å¿åã³è±ããšãã«ã¢ã«ãã«åãå«ãïŒã¯ãäžè¬åŒ
ïŒïœïŒã§è¡šããããååç©ããã®çœ®æåºäžã«ã
äœçŽã¢ã«ã³ãã·åºãããšãã«äœçŽã¢ã«ã³ãã·åºå
ã¯ïŒåã³äœçŽã¢ã«ã³ãã·äœçŽã¢ã«ã³ãã·åºãå«ã
å Žåã«ã該ååç©ãé žã®ååšäžãäžæŽ»æ§æº¶åªäžã
奜ãŸããã¯ç¡æ°Žæº¶åªã䜿çšããŠãâ30ã100âã®æž©
床æ¡ä»¶äžã«ïŒãïŒæéçšåºŠãèŠããŠåå¿ãããã
ãšã«ããè¡ãªãããããã«ãã察å¿ããæ°Žé žåºã
æãããã©ãã³èªå°äœãååŸããããšãã§ããã
ããã§é žãšããŠã¯äŸãã°ç¡æ°Žå¡©åã¢ã«ãããŠã ã
å¡©åã¹ãºãããåããŠçŽ ãå¡©åäºéãèåæ°ŽçŽ ãª
ã©ãäŸç€ºã§ããäžæŽ»æ§æº¶åªãšããŠã¯äŸãã°ããã
ãã³ãŒã³ããã«ãšã³ããã³ãŒã³çã®è³éŠæçåæ°Ž
çŽ ïŒãããµã³ããªã¯ã¿ã³çã®é£œåçåæ°ŽçŽ ïŒã¢ã»
ããããªã«çãäŸç€ºã§ãããäžèšåå¿ã«ãããäž
è¬åŒïŒïœïŒã®ååç©ã«å¯Ÿãã觊åªã®äœ¿çšå²åãš
ããŠã¯ãéåžžåè ïŒã¢ã«ã«å¯ŸããŠåŸè ãïŒã10ã¢
ã«éçšåºŠãšããã°ããã è±ã¢ã·ã«ååå¿ã¯äžè¬åŒïŒïœïŒã§è¡šãããã
ååç©ããã®çœ®æåºã«ççŽ æ°ïŒã10ã®ã¢ã«ã«ãã€
ã«ãªãã·åºãã·ã¯ãã¢ã«ãã«ã«ã«ããã«ãªãã·
åºããã³ãŸã€ã«ãªãã·åºãå«ãå Žåã«ã該ååç©
ãéåžžäžè¬çã«åºãè¡ãªããããšã¹ãã«ã®å æ°Žå
解åå¿ãšåæ§ã«ããŠå®æœåºæ¥ãã ãã®è±ã¢ã·ã«åã¯é žåã¯ã¢ã«ã«ãªè§Šåªã®ååš
äžãäžæŽ»æ§æº¶åªäžãïŒã100âã®æž©åºŠæ¡ä»¶äžã«ã
ïŒãïŒæéçšåºŠãèŠããŠè¡ãªãããã觊åªãšããŠ
ã¯äŸãã°å¡©é žãç¡«é žãå¡©åã¢ã«ãããŠã çã®ç¡æ©
é žïŒé ¢é žãè»é žçã®ææ©é žïŒæ°Žé žåãããªãŠã ã
çé žãããªãŠã ãæ°Žé žåã«ãªãŠã çã®ç¡æ©å¡©åºïŒ
ã¢ã³ã¢ãã¢ãããªãšãã«ã¢ãã³çã®ææ©å¡©åºãªã©
ãæãããããäžæŽ»æ§æº¶åªãšããŠã¯æ°Žãã¡ãã«ã¢
ã«ã³ãŒã«ããšãã«ã¢ã«ã³ãŒã«çã®ã¢ã«ã³ãŒã«é¡ïŒ
é ¢é žãããããªã³é žçã®ã«ã«ãã³é žããšãã«ãšãŒ
ãã«çã®ãšãŒãã«é¡ããžã¡ãã«ãã«ã ã¢ãããã¢
ã»ãã¢ããçã®ã¢ããé¡ãæããããã ããããŠäžèšè±ãã³ãžã«åãè±ã¢ã«ãã«ååã³
è±ã¢ã·ã«ååå¿ã®å°ãªããšãïŒçš®ã®åå¿ãè¡ãªã
ããšã«ãããR1ïŒïŒR4ïŒoã®ããããå°ãªããšãïŒ
çš®ãæ°Žé žåºã§ããææã®äžè¬åŒïŒïŒã§è¡šããã
ããã©ãã³èªå°äœãååŸã§ããã åæ¬çºæã®ãã©ãã³èªå°äœïŒïŒã®ãã¡ïŒR4ïŒ
oã®ïŒã€ãççŽ æ°ïŒã10ã®ã¢ã«ã«ãã€ã«ãªãã·åºã
ã·ã¯ãã¢ã«ãã«ã«ã«ããã«ãªãã·åºãåã¯ãã³ãŸ
ã€ã«ãªãã·åºã§ããååç©ã¯ããŸãäžèšã§è£œé ã
ããïŒR4ïŒoã®å°ããšãïŒçš®ãæ°Žé žåºã§ããåå
ç©ãã¢ã·ã«ååå¿ãããããšã«ãã€ãŠãååŸãã
ããšãåºæ¥ãã該ã¢ã·ã«ååå¿ã¯ã¢ã·ã«åå€ãšã
ãŠäŸãã°ççŽ æ°ïŒã10ã®ã¢ã«ã«ã³é žãã©ã€ããã·
ã¯ãã¢ã«ãã«ã«ã«ãã³é žãã©ã€ããå®æ¯éŠé žãã©
ã€ãçã®é žãã©ã€ãåã¯ççŽ æ°ïŒã20ã®ã¢ã«ã«ã³
é žç¡æ°Žç©ãã·ã¯ãã¢ã«ãã«ã«ã«ãã³é žç¡æ°Žç©ãå®
æ¯éŠé žç¡æ°Žç©çã®é žç¡æ°Žç©ãçšããŠåžžæ³ã«åŸãè¡
ãªããããé žãã©ã€ããçšããåå¿ã¯ãäžæŽ»æ§æº¶
åªäžãå¿ èŠã§ããã°è±ããã²ã³åæ°ŽçŽ å€äŸãã°ã
ãªãšãã«ã¢ãã³ããžã€ãœãããã«ãšãã«ã¢ãã³ã
ãªãžã³ãïŒïŒ®âãžãšãã«ã¢ããªã³çã®ã¢ãã³é¡
ãçšããŠãâ50ã150âã®æž©åºŠç¯å²å ã§ãïŒã24æ
éçšåºŠãèŠããŠè¡ãªãããã é žç¡æ°Žç©ãçšããåå¿ã¯ãäžæŽ»æ§æº¶åªäžã宀枩
ã200âã®æž©åºŠç¯å²ã§ãïŒã10æéçšåºŠã§è¡ãªã
ãããäžèšååå¿ã«ãããäžæŽ»æ§æº¶åªãšããŠã¯ã
äŸãã°ããããã³ãŒã³ãå¡©åãã³ãŒã³çã®è³éŠæ
çåæ°ŽçŽ é¡ïŒããªãžã³ãïŒïŒ®âãžã¡ãã«ã¢ããª
ã³çã®ã¢ãã³é¡ïŒãšãã«ãšãŒãã«çã®ãšãŒãã«
é¡ïŒãžã¯ããã¡ã¿ã³ããžã¯ãããšã¿ã³ãã¯ããã
ã«ã çã®ããã²ã³åçåæ°ŽçŽ é¡ã䜿çšããããšã
ã§ããããŸãäžèšã«ãããäžè¬åŒïŒïŒã®ååç©
ã«å¯Ÿããã¢ã·ã«åå€ã®äœ¿çšå²åã¯ãåè ïŒã¢ã«ã«
察ããŠåŸè ãïŒã¢ã«ä»¥äžã奜ãŸããã¯ïŒãïŒã¢ã«
éãšããã®ãè¯ããããããŠäžè¬åŒïŒïŒã§è¡šã
ãããååç©äžïŒR4ïŒoã®å°ãªããšãïŒã€ãççŽ
æ°ïŒã10ã®ã¢ã«ã«ãã€ã«ãªãã·åºãã·ã¯ãã¢ã«ã
ã«ã«ã«ããã«ãªãã·åºåã¯ãã³ãŸã€ã«ãªãã·åºã§
ããååç©ãåŸãã æ¬çºæã®ãã©ãã³èªå°äœïŒïŒã®ãã¡R1ãäœ
çŽã¢ã«ã³ãã·åºã§ããååç©ãåã¯ïŒR4ïŒoã®å°
ããšãäžã€ãäœçŽã¢ã«ã³ãã·äœçŽã¢ã«ã³ãã·åºã§
ããååç©ã¯ããŸãåèšã§è£œé ãããR1ïŒïŒR4ïŒo
ã®å°ããšãïŒã€ãæ°Žé žåºã§ããååç©ãã¢ã«ãã«
ååã¯ã¢ã«ã³ãã·ã¢ã«ãã«åããããšã«ãã€ãŠã
補é ããããšãåºæ¥ãã 該ã¢ã«ãã«ååã³ã¢ã«ã³ãã·ã¢ã«ãã«ååå¿ã¯
該ã¢ã«ãã«ååå¿ã¯ã¢ã«ãã«åå€ãšããŠäŸãã°äœ
çŽã¢ã«ãã«ãã©ã€ããäœçŽã¢ã«ã³ãã·äœçŽã¢ã«ã
ã«ãã©ã€ãããžã¢ã«ãã«ç¡«é žããžã¢ãŸã¢ã«ã«ã³ç
ãçšããŠè¡ãªãããšãã§ãããäœçŽã¢ã«ãã«ãã©
ã€ãåã³äœçŽã¢ã«ã³ãã·äœçŽã¢ã«ãã«ãã©ã€ãã
çšããåå¿ã¯ãåèšã¢ã·ã«ååå¿ãšåæ§ã®æ¹æ³ã«
ãã€ãŠè¡ãªãããããžã¢ã«ãã«ç¡«é žãçšããåå¿
ã¯ãäžæŽ»æ§æº¶åªäžã«ãŠå®€æž©ã150âã«ãŠè¡ãªãã
ããããã§ãžã¢ã«ãã«ç¡«é žãšããŠã¯äŸãã°ãžã¡ã
ã«ç¡«é žããžãšãã«ç¡«é žçãäŸç€ºã§ãããäžæŽ»æ§æº¶
åªãšããŠã¯ãã³ãŒã³ããã«ãšã³çã®è³éŠæçåæ°Ž
çŽ é¡ïŒãšãã«ãšãŒãã«çã®ãšãŒãã«é¡ãäŸç€ºã§ã
ããæ¯ãããŠäžè¬åŒïŒïŒäžR1ãäœçŽã¢ã«ã³ã
ã·åºåã¯ïŒR4ïŒoã®å°ããšãïŒã€ãäœçŽã¢ã«ã³ã
ã·äœçŽã¢ã«ã³ãã·åºã§ããææã®ãã©ãã³èªå°äœ
ãååŸåºæ¥ãã äžèšããåçš®æ¹æ³ã«åŸãåŸããããã©ãã³èªå°
äœäžãR1ïŒïŒR4ïŒoã®å°ãªããšãïŒçš®ãæ°Žé žåºã§ã
ãååç©ã¯ããããäŸãã°æ°Žé žåãããªãŠã çã®
ã¢ã«ã«ãªã«ããåŠçããããšã«ããè¬ççã«èš±å®¹
ãããã¢ã«ã«ãªå¡©ãšããããšãã§ããããããå¡©
ã亊æ¬çºæã®æå¹æåãšããŠå©çšã§ããã äžèšå€«ã ã®å·¥çšã§ã®ç®çååç©ã¯ãéåžžã®åé¢
æ段ã«ãã容æã«åé¢ç²Ÿè£œããããšãã§ãããã
ãåé¢æ段ãšããŠã¯äŸãã°æº¶åªæœåºæ³ãåžéæ³ã
åçµæ¶æ³ãåžçã¯ãããã°ã©ãã€ãŒãã€ãªã³äº€æ
ã¯ãããã°ã©ãã€ãŒãååãµããã¯ãããã°ã©ã
ã€ãŒçãäŸç€ºã§ããã ããããŠåŸãããäžè¬åŒïŒïŒã§è¡šããããã
ã©ãã³èªå°äœåã³ãã®å¡©ã¯ãããããïŒâãªãã
ã·ã²ããŒãŒãé»å®³ããäœçšãæããŠããããŸãæ¯
æ§ãäœããå¯äœçšãå°ãªããïŒâãªããã·ã²ããŒ
ãŒé»å®³å€ãšããŠæ¥µããŠæçšã§ããããŸããããã¯
ãã®æããé¡èãªïŒâãªããã·ã²ããŒãŒé»å®³äœçš
ãå©çšããŠãåæ¯ãççãã¢ã¬ã«ã®ãŒçã®çç¶ã«
察ããäºé²è¬ä¹è³æ²»çè¬ãšããŠæçšã§ãããåæ¬
çºæååç©ã®ãã¡R4ãæ°Žé žåºä»¥å€ã®ãã®ã¯åèš
è¬çäœçšã®æç¶æéãé·ããšããç¹åŸŽãæããŠã
ãããŸãæ¬çºæååç©ã®R4ã®çœ®æäœçœ®ã¯ç¹ã«é
å®ãããåºãç¯å²ããé©å®éžæãããã第ïŒïŒïŒ
äœãç¹ã«å¥œãŸããã äžè¬åŒïŒïŒã®ååç©åã³ãã®å¡©ã¯ãéåžžäžè¬
çãªå»è¬è£œå€ã®åœ¢æ ã§çšããããã補å€ã¯é垞䜿
çšãããå å¡«å€ãå¢éå€ãçµåå€ãä»æ¹¿å€ã厩å£
å€ãè¡šé¢æŽ»æ§å€ãæ»æ²¢å€çã®åžéå€ãããã¯è³Šåœ¢
å€ãçšããŠèª¿è£œãããããã®å»è¬è£œå€ãšããŠã¯å
çš®ã®åœ¢æ ãæ²»çç®çã«å¿ããŠéžæã§ãããã®ä»£è¡š
çãªãã®ãšããŠé å€ãåŽé§å€ãäžžå€ãæ£å€ã液
å€ãæžæ¿å€ãä¹³å€ãé¡ç²å€ãã«ãã»ã«å€ãåå€ã
泚å°å€ïŒæ¶²å€ãæžæ¿å€çïŒçãæãããããé å€
ã®åœ¢æ ã«æ圢ããã«éããŠã¯ãæ äœãšããŠãã®å
éã§å ¬ç¥ã®ãã®ãåºã䜿çšã§ããäŸãã°ä¹³ç³ãçœ
ç³ãå¡©åãããªãŠã ããããŠç³ãå°¿çŽ ããã³ã
ã³ãçé žã«ã«ã·ãŠã ãã«ãªãªã³ãçµæ¶ã»ã«ããŒ
ã¹ãã±ã€é žçã®è³Šåœ¢å€ãæ°Žããšã¿ããŒã«ãããã
ããŒã«ãåã·ãããããããŠç³æ¶²ããã³ãã³æ¶²ã
ãŒã©ãã³æº¶æ¶²ãã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ãã»
ã©ãã¯ãã¡ãã«ã»ã«ããŒã¹ããªã³é žã«ãªãŠã ãã
ãªããã«ãããªãã³çã®çµåå€ã也ç¥ãã³ãã³ã
ã¢ã«ã®ã³é žãããªãŠã ãã«ã³ãã³æªãã©ããã©ã³
æªãçé žæ°ŽçŽ ãããªãŠã ãçé žã«ã«ã·ãŠã ãããª
ãªãã·ãšãã¬ã³ãœã«ãã¿ã³èèªé žãšã¹ãã«é¡ãã©
ãŠãªã«ç¡«é žãããªãŠã ãã¹ãã¢ãªã³é žã¢ãã°ãªã»
ãªãããã³ãã³ãä¹³ç³çã®åŽ©å£å€ãçœç³ãã¹ãã¢
ãªã³ãã«ã«ãªãã¿ãŒãæ°ŽçŽ æ·»å æ²¹çã®åŽ©å£æå¶
å€ã第ïŒçŽã¢ã³ã¢ããŠã å¡©åºãã©ãŠãªã«ç¡«é žãã
ãªãŠã çã®åžåä¿é²å€ãã°ãªã»ãªã³ããã³ãã³ç
ã®ä¿æ¹¿å€ããã³ãã³ãä¹³ç³ãã«ãªãªã³ããã³ãã
ã€ããã³ãã€ãç¶ã±ã€é žçã®åžçå€ã粟補ã¿ã«
ã¯ãã¹ãã¢ãªã³é žå¡©ãããŠé žæªãããªãšãã¬ã³ã°
ãªã³ãŒã«çã®æ»æ²¢å€çãäŸç€ºã§ãããããã«é å€
ã¯å¿ èŠã«å¿ãéåžžã®å€ç®ãæœããé å€ãäŸãã°ç³
è¡£é ããŒã©ãã³è¢«å é ãè žæº¶è¢«é ããã€ã«ã ã³ãŒ
ãã€ã³ã°é ãããã¯äºéé ãå€å±€é ãšããããšã
ã§ãããäžžå€ã®åœ¢æ ã«æ圢ããã«éããŠã¯ãæ äœ
ãšããŠåŸæ¥å ¬ç¥ã®ãã®ãåºã䜿çšã§ããäŸãã°ã
ããŠç³ãä¹³ç³ããã³ãã³ãã«ã«ãªèã硬åæ€ç©
æ²¹ãã«ãªãªã³ãã¿ã«ã¯çã®è³Šåœ¢å€ãã¢ã©ãã¢ãŽã
æªããã©ã¬ã³ãæªããŒã©ãã³ããšã¿ããŒã«çã®çµ
åå€ãã©ããã©ã³ã«ã³ãã³çã®åŽ©å£å€çãäŸç€ºã§
ãããåå€ã®åœ¢æ ã«æ圢ããã«éããŠã¯ãæ äœãš
ããŠåŸæ¥å ¬ç¥ã®ãã®ãåºã䜿çšã§ããäŸãã°ããª
ãšãã¬ã³ã°ãªã³ãŒã«ãã«ã«ãªèãé«çŽã¢ã«ã³ãŒ
ã«ãé«çŽã¢ã«ã³ãŒã«ã®ãšã¹ãã«é¡ããŒã©ãã³ãå
åæã°ãªã»ã©ã€ãçãæããããšãã§ããã泚å°
å€ãšããŠèª¿è£œãããå Žåã«ã¯ã液å€åã³æžæ¿å€ã¯
殺èããããã€è¡æ¶²ãšç匵ã§ããã®ã奜ãŸããã
ããã液å€ãä¹³å€åã³æžæ¿å€ã®åœ¢æ ã«æ圢ããã«
éããŠã¯ãåžéå€ãšããŠãã®åéã«ãããŠæ £çšã
ããŠãããã®ããã¹ãŠäœ¿çšã§ããäŸãã°æ°Žããšã
ã«ã¢ã«ã³ãŒã«ããããã¬ã³ã°ãªã³ãŒã«ããšããã·
åã€ãœã¹ãã¢ãªã«ã¢ã«ã³ãŒã«ãããªãªãã·åã€ãœ
ã¹ãã¢ãªã«ã¢ã«ã³ãŒã«ãããªãªãã·ãšãã¬ã³ãœã«
ãã¿ã³èèªé žãšã¹ãã«é¡çãæããããšãã§ã
ãããªãããã®å Žåç匵æ§ã®æº¶æ¶²ã調補ããã«å
åãªéã®é£å¡©ããããŠç³ãããã¯ã°ãªã»ãªã³ãå»
è¬è£œå€äžã«å«æããããŠãããããŸãéåžžã®æº¶è§£
è£å©å€ãç·©è¡å€ãç¡çåå€çãæ·»å ããŠãããã
æŽã«å¿ èŠã«å¿ããŠçè²å€ãä¿åå€ãéŠæã颚å³
å€ãçå³å€çãä»ã®å»è¬åãå»è¬è£œå€äžã«å«æã
ãããŠãããã ãŸãäžèšãã©ãã³èªå°äœåã³ãã®å¡©ãåŽé§å€ã®
圢æ ã«ããéã«ã¯ãåæ£å€åã³åŽå°å€ãšããŠãã®
åéã§å ¬ç¥ã®ãã®ãåºã䜿çšã§ããåæ£å€ãšããŠ
ã¯äŸãã°å€§è±ã¬ã·ãã³ãåµé»ã¬ã·ãã³çã®ã¬ã·ã
ã³é¡ããªã¬ã€ã³é žããªããŒã«é žããªãã¬ã³é žçã®
èèªé žããœã«ãã¿ã³ããªãªã¬ãŒãããœã«ãã¿ã³ã¢
ããªã¬ãŒãçã®ãœã«ãã¿ã³é¡çãäŸç€ºã§ããããŸ
ãåŽå°å€ãšããŠäŸãã°ãã¬ãªã³11ããã¬ãªã³12ã
ãã¬ãªã³114çã®éåžžäžçæ§æ¶²åã¬ã¹ãäŸç€ºã§ã
ãã äžè¬åŒïŒïŒã®ååç©åã¯ãã®å¡©ã®å»è¬è£œå€äž
ã«å«æãããã¹ãéãšããŠã¯ãç¹ã«éå®ãããåº
ç¯å²ã«é©å®éžæãããããéåžžå»è¬è£œå€äžïŒã70
ééïŒ ã奜ãŸããã¯ïŒã30ééïŒ ã§ããã äžèšå»è¬è£œå€ã®æäžæ¹æ³ã¯ç¹ã«å¶éã¯ãªããå
皮補å€åœ¢æ ãæ£è ã®å¹Žéœ¢ãæ§å¥ãã®ä»ã®æ¡ä»¶ãæ£
è ã®çšåºŠçã«å¿ããæ¹æ³ã§æäžããããäŸãã°é
å€ãäžžå€ã液å€ãæžæ¿å€ãä¹³å€ãé¡ç²å€åã³ã«ã
ã»ã«å€ã®å Žåã«ã¯çµå£æäžãããããŸã泚å°å€ã®
å Žåã«ã¯åç¬ã§ãããã¯ãããŠç³ãã¢ããé žçã®
éåžžã®è£æ¶²ãšæ··åããŠéèå æäžãããæŽã«ã¯å¿
èŠã«å¿ããŠåç¬ã§çèå ãç®å ãç®äžãããã¯è ¹
è å æäžããããåå€ã®å Žåã«ã¯çŽè žå æäžãã
ããååŽé§å€ã¯å£åã¯éŒ»ããåŽé§ããŠæ°ç®¡æ¯ãžæ
äžãããã æ¬çºæã®ïŒâãªããã·ã²ããŒãŒé»å®³å€ã®æäžé
ã¯çšæ³ãæ£è ã®å¹Žéœ¢ãæ§å¥ãã®ä»ã®æ¡ä»¶ãçŸæ£ã®
çšåºŠçã«ããé©å®éžæãããããéåžžæå¹æåã§
ããäžè¬åŒïŒïŒã®ååç©ã®éã¯ïŒæ¥åœãäœéïŒ
KgåœãçŽ0.005ã10mgã奜ãŸããã¯0.1ãïŒmgãšã
ãã®ãããã 以äžã«åèäŸãè¬çè©Šéšçµæåã³è£œå€äŸãæã
ãã åèäŸ ïŒ ïŒâããããã·âïŒâïœâããã·ã«ãªãã·â
ïŒïŒïŒâãžã¡ããã·ã¢ã»ãããšãã³7.2ïœãšïŒïŒ
ïŒâãžãã³ãžã«ãªãã·ãã³ãŸã€ã«ã¯ãã©ã€ã11ïœ
ãšãã也ç¥ããªãžã³15mlã«æº¶è§£ãã120âã§ïŒæ
éåå¿ãããããã®åå¿æº¶æ¶²ã宀枩ãŸã§å·åŽãã
æ°·âåžå¡©é žäžã«å ãããšãŒãã«æœåºããããšãŒã
ã«å±€ãæ°Žãçé žã«ãªãŠã 氎溶液ãæ°Žã§é 次æŽæµã
也ç¥ããããšãŒãã«ãæžå§çå»ããŠæ²¹ç¶ã®ïŒâ
ïŒ3â²ïŒ4â²âãžãã³ãžã«ãªãã·ïŒãã³ãŸã€ã«ãªãã·
âïŒâïœâããã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·
ã¢ã»ãããšãã³16ïœãåŸãã åèäŸ ïŒ åèšåèäŸïŒã§åŸãïŒâïŒ3â²ïŒ4â²âãžãã³ãžã«
ãªãã·ïŒãã³ãŸã€ã«ãªãã·âïŒâïœâããã·ã«ãª
ãã·âïŒïŒïŒâãžã¡ããã·ã¢ã»ãããšãã³16ïœã
也ç¥ããªãžã³30mlã«æº¶è§£ãã次ã«ç²æªæ°Žé žåã«ãª
ãŠã 15ïœãå ã60âã«å ç±ããæ¹æããïŒæéå
å¿ããããšãåå¿æº¶æ¶²ã¯ç²è¹ã«ãªãããã®åå¿æº¶
液ãåèšåèäŸïŒãšåæ§ã«æ°·âå¡©é žäžã«å ãé ¢é ž
ãšãã«ã§æœåºãããé ¢é žãšãã«å±€ãæ°Žãçé žã«ãª
ãŠã 氎溶液ãæ°Žã®é ã«æŽæµåŸã也ç¥ãããé ¢é žãš
ã¹ãã«ãçå»ããåŸãããé»è²æ²æ®¿ããé ¢é žãšã
ã«âã¡ã¿ããŒã«ã®æ··å溶åªã«ãŠåçµæ¶ããããšã«
ãããé»è²éç¶æ¶ã®ïŒâããããã·â3â²ïŒ4â²âãž
ãã³ãžã«ãªãã·âïŒâïœâããã·ã«ãªãã·âïŒïŒ
ïŒâãžã¡ããã·ãžãã³ãŸã€ã«ã¡ã¿ã³10ïœãåŸãã m.p.ïŒ96ã97â å®æœäŸ ïŒ ïŒâããããã·â3â²ïŒ4â²âãžãã³ãžã«ãªãã·â
ïŒâïœâããã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãž
ãã³ãŸã€ã«ã¡ã¿ã³10ïœãšé ¢é žãããªãŠã ïŒïœãš
ããæ°·é ¢é ž30mlã«æº¶è§£ããå ç±éæµãïŒæéè¡ãª
ããåå¿æº¶æ¶²ããšãŒãã«å«ææ°·æ°Žã«å ãæ¯ãšãã
ããæ²æ®¿ç©ãåããããã®æ²æ®¿ç©ããé ¢é žãšã
ã«ã«ãŠåçµæ¶ããŠ3â²ïŒ4â²âãžãã³ãžã«ãªãã·âïŒ
âïœâããã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©
ãã³7.5ïœïŒm.pïŒ132ã134âïŒãåŸãã å®æœäŸ ïŒ äžèšå®æœäŸïŒã§åŸãååç©ã®ïŒïœãã¡ã¿ããŒã«
âé ¢é žãšãã«ïŒïŒïŒïŒïŒ500ml溶液ãšã10ïŒ pdâ
C300mgã觊åªãšããŠè±ãã³ãžã«åããšã¿ããŒã«
ããåçµæ¶ããŠãç¡è²ããªãºã ç¶æ¶ã§ãã3â²ïŒ
4â²âãžããããã·âïŒâïœâããã·ã«ãªãã·â
ïŒïŒïŒâãžã¡ããã·ãã©ãã³2.6ïœãåŸãã m.p.ïŒ178ã180â å®æœäŸ ïŒ äžèšå®æœäŸïŒåã³å®æœäŸïŒãšåæ§ã«ããŠé©åœãª
åºçºåæãçšããŠä»¥äžã®ååç©ãåŸãã 3â²ïŒ4â²âãžããããã·âïŒâïœâããã«ãã«ãª
ãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ m.p.176ã178â æ·¡é»è²ããªãºã ç¶æ¶ å®æœäŸ ïŒ ç¡æ°Žå¡©åã¢ã«ãããŠã 0.69ïœïŒ0.002ã¢ã«ïŒã
也ç¥ããããã³ãŒã³70mlã«æº¶ããããã®æº¶æ¶²ãå·
åŽãããã®ã«3â²ïŒ4â²âãžããããã·âïŒâïœâã
ãã«ãã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³
1.0ïœïŒ0.002ã¢ã«ïŒã也ç¥ããããã³ãŒã³10mlã«
溶ããããã®ã滎äžãã滎äžåŸïŒæé60ã70âã«
ãŠæ¹æåå¿ãããããã®æº¶æ¶²ãæ°·100ïœãšå¡©é ž10
ïœãšã®æ··å液äžã«å ããåŸãå液ããŒãã«ãŠãã
ããã³ãŒã³ãåé¢ããæ°Žèžæ°èžçã«ãŠããããã³
ãŒã³ãçå»ãããæ®çæ²æ®¿ç©ãæ°Žã§æŽæµãããã
ãé ¢é žãšãã«âã¡ã¿ããŒã«ã§åçµæ¶ããŠãæ·¡é»è²
éç¶æ¶ã®ïŒïŒ3â²ïŒ4â²âããªããããã·âïŒâïœâ
ããã«ãã«ãªãã·âïŒâã¡ããã·ãã©ãã³0.89ïœ
ãåŸãã m.p.ïŒ248ã249â å®æœäŸ ïŒ ïŒïŒïŒâãžãã³ãžã«ãªãã·âïŒâãã€ãããã·
â5â²âïœâããã·ã«ãªãã·â4â²ïŒ6â²âãžã¡ããã·
ã«ã«ã³ã³2.98ïœïŒ0.005ã¢ã«ïŒãšäºé žåãŒã¬ã³3.33
ïœïŒ0.03ã¢ã«ïŒãšã粟補ããã€ãœã¢ãã«ã¢ã«ã³ãŒ
ã«50mlã«æº¶è§£ããïŒæéå ç±éæµãåå¿ãããã
ãã®åå¿æº¶æ¶²ããéå±ãŒã¬ã³ãå¥ãããšããã¬
ãŒã¿ãŒã«ãŠã»ãšãã©ã®æº¶åªãåãé€ããæ²æ®¿ç©ã
äžå€æŸçœ®ããåŸããã®æ²æ®¿ãé ¢é žãšãã«ã«ãŠåçµ
æ¶ããŠã3â²ïŒ4â²âãžãã³ãžã«ãªãã·âïŒâïœâã
ãã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³2.52
ïœãåŸãã m.p.ïŒ132ã134â å®æœäŸ ïŒ 3â²ïŒ4â²âãžãã³ãžã«ãªãã·âïŒâïœâããã·ã«
ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³1.36ïœ
ïŒ0.002ã¢ã«ïŒã10ïŒ æ¿å¡©é žå«æé ¢é ž20mlã«æº¶è§£
ãã50ã60âã§ïŒæéå ç±ãããåå¿æº¶æ¶²ãæ°Žã«
å ãæ²æ®¿ç©ãåŸãããã®æ²æ®¿ç©ãããšã¿ããŒã«ã
ãåçµæ¶ããŠã3â²ïŒ4â²âãžããããã·âïŒâïœâ
ããã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³
0.75ïœãåŸãã m.p.178ã180â ç¡è²ããªãºã ç¶æ¶ å®æœäŸ ïŒ 3â²ïŒ4â²âãžããããã·âïŒâïœâããã·ã«ãªã
ã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³2.0ïœåã³ç¡æ°Ž
é ¢é žïŒïœãããªãžã³ïŒmlã«æº¶è§£ãã100ã120âã§
ïŒæéå ç±ãããå·åŸåå¿æ··åç©ã«æ°Žãå ãæåº
æ¶ãåããããšã¿ããŒã«ããåçµæ¶ããŠç¡è²ã
ãªãºã æ¶ã®3â²ïŒ4â²âãžã¢ã»ããã·âïŒâïœâãã
ã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³2.0ïœ
ãåŸããïŒïŒ¡æ³ïŒ m.p.125ã125.5â å®æœäŸ ïŒ 3â²ïŒ4â²âãžããããã·âïŒâïœâããã·ã«ãªã
ã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³1.4ïœåã³ããª
ãšãã«ã¢ãã³1.2mlãç¡æ°Žãžã¯ããã¡ã¿ã³20mlã«
溶解ããæ°·å·ãæ¹æäžãïœâãããµãã€ã«ã¯ãã©
ã€ã1.1ïœã®ãžã¯ããã¡ã¿ã³10ml溶液ã滎äžããã
滎äžåŸå®€æž©ã§äžå€æ¹æãããåå¿æ¶²ãæ°ŽæŽã也ç¥
åŸã溶åªãçå»ãããæ®æž£ããšã¿ããŒã«âæ°Žãã
åçµæ¶ããŠãç¡è²ç²æªç¶ã®3â²ïŒ4â²âãžâïœâãã
ãµãã€ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³
1.2ïœãåŸããïŒïŒ¢æ³ïŒ m.p.81ã81.5â å®æœäŸïŒåã³ïŒãšåæ§ã«ããŠã以äžè¡šïŒã®åå
ç©ãåŸãã
ãè¡šã
å®æœäŸ 13
3â²ïŒ4â²âãžããããã·âïŒâïœâããã·ã«ãªã
ã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ïŒïœåã³ãžã€ãœ
ãããã«ãšãã«ã¢ãã³2.1mlããžã¯ããã¡ã¿ã³20
mlã«æº¶è§£ããæ°·å·æ¹æäžã¡ããã·ã¡ãã«ã¯ãã©ã€
ãïŒïœã®ãžã¯ããã¡ã¿ã³æº¶æ¶²ïŒmlã滎äžããã宀
æž©äžå€æ¹æåŸãåå¿æ¶²ãæ°ŽæŽã也ç¥ããã溶åªã
çå»ããŠåŸãããæ®æž£ãã·ãªã«ã²ã«ã«ã©ã ã¯ãã
ãã°ã©ãã€ãŒã«ãŠç²Ÿè£œãããïŒæº¶åºæ¶²ïŒã¯ããã
ã«ã ïŒãšã¿ããŒã«âæ°Žããåçµæ¶ããŠç¡è²ç²æªç¶
æ¶ã®3â²ïŒ4â²âãžã¡ããã·ã¡ããã·âïŒâïœâãã
ã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³1.8ïœ
ãåŸãã m.p.84â 以äžæ¬çºæååç©ãçšãã補å€äŸãæããã 補å€äŸ ïŒ 3â²ïŒ4â²âãžããããã·âïŒâïœâããã·ã«ãªã
ã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ 20mg ãã³ãã³ 130mg ãã°ãã·ãŠã ã¹ãã¢ã¬ãŒã 10mgä¹³ ç³ 40mg èš 200mg åžžæ³ã«ããïŒé äžãäžèšçµæç©ã®é å€ã補é ã
ãã 補å€äŸ ïŒ 3â²ïŒ4â²âãžã¢ã»ããã·âïŒâïœâããã·ã«ãªã
ã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ 10mg ãã³ãã³ 127mg ãã°ãã·ãŠã ã¹ãã¢ã¬ãŒã 18mgä¹³ ç³ 45mg èš 200mg åžžæ³ã«ããïŒé äžãäžèšçµæç©ã®é å€ã補é ã
ãã 補å€äŸ ïŒ 3â²ïŒ4â²âãã³ãŸã€ã«ãªãã·âïŒâïœâããã·ã«
ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ 10mg ãã³ãã³ 127mg ãã°ãã·ãŠã ã¹ãã¢ã¬ãŒã 18mgä¹³ ç³ 45mg èš 200mg åžžæ³ã«ããïŒé äžãäžèšçµæç©ã補é ããã 補é äŸ ïŒ 3â²ïŒ4â²âãžâïœâãããµãã€ã«ãªãã·âïŒâïœ
âããã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ã
ã³ 1.0ïœ ãœã«ãã¿ã³ã¢ãã»ã¹ãã¬ãŒã 3.0ïœ ãã¬ãªã³11 1.5ïœãã¬ãªã³12 3.5ïœ èš 9.0ïœ åžžæ³ã«ãããïŒãã³ãäžäžèšçµæç©ã®åŽé§å€ã
補é ããã 補é äŸ ïŒ 3â²ïŒ4â²âãžã¢ã»ããã·âïŒâïœâããã·ã«ãªã
ã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ 1.0ïœ ãªã¬ã€ã³é ž 3.0ïœ ãã¬ãªã³11 1.25ïœ ãã¬ãªã³12 2.5ïœãã¬ãªã³114 1.25ïœ èš 9.0ïœ åžžæ³ã«ãããïŒãã³ãäžäžèšçµæç©ã®åŽé§å€ã
補é ããã ãè¬çè©Šéšã ïŒâãªããã·ã²ããŒãŒé»å®³äœçš é µçŽ ã®èª¿è£œ ã©ãã奜塩åºæ§çœè¡ç 现èïŒRat basophilic
leukemia cellïŒREL cellïŒãé µçŽ æºãšããŠã
ïŒâãªããã·ã²ããŒãŒã調補ããããã«ããã³
å€æ³ã€ãŒã°ã«å¹å°ã«10ïŒ ãŠã·èå è¡æž ãæ·»å ã
ãå¹å°ã§ãïŒïŒ CO2æ°æµäžã§37âã§äžèšçŽ°èã®
å¹é€ãè¡ãªããé å¿åé¢ã«ãã€ãŠçŽ°èãéããŠ
现èæ°ïŒÃ107åïŒmlã®RBL现èæµ®é液ã調補
ããã0.05Mçé žç·©è¡æ¶²ïŒPH7.4ïŒã10ïŒ ãšãã¬
ã³ã°ãªã³ãŒã«ãïŒïœMEDTAãå«ã现èæµ®é
液ãã20KHzã®è¶ é³æ³¢ã«30ç§éããããŠçŽ°èã
ç Žç ãã105000Ãïœã§60åéé å¿åé¢ãè¡ãª
ãããã®äžæž ãé µçŽ ãšããã é µçŽ æŽ»æ§æž¬å® 0.05Mçé žç·©è¡æ¶²ïŒPH7.4ãïŒïœïŒ CaCl2å
ã³ïŒïœïŒ ATPãå«ãïŒ200ÎŒã«ãåèšã§
åŸãé µçŽ 100ÎŒãšæ¬çºæã«çšããæå¹æåå
åç©1ÎŒMã5ÎŒMåã¯10ÎŒMã®å€«ã ãå ããïŒå
é30âã§æ¥è§ŠãããåŸã14Cã§æšèããã¢ã©ãã
ã³é žãçµæªæ¿åºŠ25ÎŒMïŒ30nCiïŒã«å ããŠã30â
ã§ïŒåéæ¯çªãã€ã€åå¿ãããã¯ãšã³é žãå ã
é žæ§ã«ããåå¿æ¶²ãããšãã«ãšãŒãã«ã§æœåºã
ããã®ãããšãã«ãšãŒãã«ïŒç³æ²¹ãšãŒãã«ïŒé ¢
é žïŒ85ïŒ15ïŒ0.1ïŒãå±é溶åªãšããã·ãªã«ã²
ã«èå±€ã¯ãããã°ã©ãã€ãŒã«ãŠåé¢ããïŒâãª
ããã·ã²ããŒãŒã®çæç©ã«ç±æ¥ããïŒâ
HETEïŒïŒâããããªãã·âïŒïŒïŒïŒ11ïŒ14â
ãšã€ã³ãµããã©ãšã³é žïŒã®æŸå°æŽ»æ§ã枬å®ã
ããæ¬çºæã®è©Šéšååç©ãå ããªãå Žåã®ïŒâ
HETEã®çæéã100ïŒ ãšããŠãåäŸè©Šååç©
ã®é µçŽ 掻æ§ã®é»å®³åºŠïŒïŒ ïŒãæ€èšãããäŸè©Šå
åç©ãšé µçŽ 掻æ§ã®é»å®³åºŠã倫ã äžèšã«è¡šç€ºã
ãã äŸè©Šååç© ïŒ 3â²ïŒ4â²âãžããããã·âïŒâïœâããã·ã«ãª
ãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ ïŒ 3â²ïŒ4â²âãžããããã·âïŒâïœâããã«ãã«
ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ ïŒ 3â²ïŒ4â²âãžã¢ã»ããã·âïŒâïœâããã·ã«ãª
ãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ ïŒ 3â²ïŒ4â²âãžããããªãã«ãªãã·âïŒâïœâã
ãã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³
ã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ïŒïœåã³ãžã€ãœ
ãããã«ãšãã«ã¢ãã³2.1mlããžã¯ããã¡ã¿ã³20
mlã«æº¶è§£ããæ°·å·æ¹æäžã¡ããã·ã¡ãã«ã¯ãã©ã€
ãïŒïœã®ãžã¯ããã¡ã¿ã³æº¶æ¶²ïŒmlã滎äžããã宀
æž©äžå€æ¹æåŸãåå¿æ¶²ãæ°ŽæŽã也ç¥ããã溶åªã
çå»ããŠåŸãããæ®æž£ãã·ãªã«ã²ã«ã«ã©ã ã¯ãã
ãã°ã©ãã€ãŒã«ãŠç²Ÿè£œãããïŒæº¶åºæ¶²ïŒã¯ããã
ã«ã ïŒãšã¿ããŒã«âæ°Žããåçµæ¶ããŠç¡è²ç²æªç¶
æ¶ã®3â²ïŒ4â²âãžã¡ããã·ã¡ããã·âïŒâïœâãã
ã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³1.8ïœ
ãåŸãã m.p.84â 以äžæ¬çºæååç©ãçšãã補å€äŸãæããã 補å€äŸ ïŒ 3â²ïŒ4â²âãžããããã·âïŒâïœâããã·ã«ãªã
ã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ 20mg ãã³ãã³ 130mg ãã°ãã·ãŠã ã¹ãã¢ã¬ãŒã 10mgä¹³ ç³ 40mg èš 200mg åžžæ³ã«ããïŒé äžãäžèšçµæç©ã®é å€ã補é ã
ãã 補å€äŸ ïŒ 3â²ïŒ4â²âãžã¢ã»ããã·âïŒâïœâããã·ã«ãªã
ã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ 10mg ãã³ãã³ 127mg ãã°ãã·ãŠã ã¹ãã¢ã¬ãŒã 18mgä¹³ ç³ 45mg èš 200mg åžžæ³ã«ããïŒé äžãäžèšçµæç©ã®é å€ã補é ã
ãã 補å€äŸ ïŒ 3â²ïŒ4â²âãã³ãŸã€ã«ãªãã·âïŒâïœâããã·ã«
ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ 10mg ãã³ãã³ 127mg ãã°ãã·ãŠã ã¹ãã¢ã¬ãŒã 18mgä¹³ ç³ 45mg èš 200mg åžžæ³ã«ããïŒé äžãäžèšçµæç©ã補é ããã 補é äŸ ïŒ 3â²ïŒ4â²âãžâïœâãããµãã€ã«ãªãã·âïŒâïœ
âããã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ã
ã³ 1.0ïœ ãœã«ãã¿ã³ã¢ãã»ã¹ãã¬ãŒã 3.0ïœ ãã¬ãªã³11 1.5ïœãã¬ãªã³12 3.5ïœ èš 9.0ïœ åžžæ³ã«ãããïŒãã³ãäžäžèšçµæç©ã®åŽé§å€ã
補é ããã 補é äŸ ïŒ 3â²ïŒ4â²âãžã¢ã»ããã·âïŒâïœâããã·ã«ãªã
ã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ 1.0ïœ ãªã¬ã€ã³é ž 3.0ïœ ãã¬ãªã³11 1.25ïœ ãã¬ãªã³12 2.5ïœãã¬ãªã³114 1.25ïœ èš 9.0ïœ åžžæ³ã«ãããïŒãã³ãäžäžèšçµæç©ã®åŽé§å€ã
補é ããã ãè¬çè©Šéšã ïŒâãªããã·ã²ããŒãŒé»å®³äœçš é µçŽ ã®èª¿è£œ ã©ãã奜塩åºæ§çœè¡ç 现èïŒRat basophilic
leukemia cellïŒREL cellïŒãé µçŽ æºãšããŠã
ïŒâãªããã·ã²ããŒãŒã調補ããããã«ããã³
å€æ³ã€ãŒã°ã«å¹å°ã«10ïŒ ãŠã·èå è¡æž ãæ·»å ã
ãå¹å°ã§ãïŒïŒ CO2æ°æµäžã§37âã§äžèšçŽ°èã®
å¹é€ãè¡ãªããé å¿åé¢ã«ãã€ãŠçŽ°èãéããŠ
现èæ°ïŒÃ107åïŒmlã®RBL现èæµ®é液ã調補
ããã0.05Mçé žç·©è¡æ¶²ïŒPH7.4ïŒã10ïŒ ãšãã¬
ã³ã°ãªã³ãŒã«ãïŒïœMEDTAãå«ã现èæµ®é
液ãã20KHzã®è¶ é³æ³¢ã«30ç§éããããŠçŽ°èã
ç Žç ãã105000Ãïœã§60åéé å¿åé¢ãè¡ãª
ãããã®äžæž ãé µçŽ ãšããã é µçŽ æŽ»æ§æž¬å® 0.05Mçé žç·©è¡æ¶²ïŒPH7.4ãïŒïœïŒ CaCl2å
ã³ïŒïœïŒ ATPãå«ãïŒ200ÎŒã«ãåèšã§
åŸãé µçŽ 100ÎŒãšæ¬çºæã«çšããæå¹æåå
åç©1ÎŒMã5ÎŒMåã¯10ÎŒMã®å€«ã ãå ããïŒå
é30âã§æ¥è§ŠãããåŸã14Cã§æšèããã¢ã©ãã
ã³é žãçµæªæ¿åºŠ25ÎŒMïŒ30nCiïŒã«å ããŠã30â
ã§ïŒåéæ¯çªãã€ã€åå¿ãããã¯ãšã³é žãå ã
é žæ§ã«ããåå¿æ¶²ãããšãã«ãšãŒãã«ã§æœåºã
ããã®ãããšãã«ãšãŒãã«ïŒç³æ²¹ãšãŒãã«ïŒé ¢
é žïŒ85ïŒ15ïŒ0.1ïŒãå±é溶åªãšããã·ãªã«ã²
ã«èå±€ã¯ãããã°ã©ãã€ãŒã«ãŠåé¢ããïŒâãª
ããã·ã²ããŒãŒã®çæç©ã«ç±æ¥ããïŒâ
HETEïŒïŒâããããªãã·âïŒïŒïŒïŒ11ïŒ14â
ãšã€ã³ãµããã©ãšã³é žïŒã®æŸå°æŽ»æ§ã枬å®ã
ããæ¬çºæã®è©Šéšååç©ãå ããªãå Žåã®ïŒâ
HETEã®çæéã100ïŒ ãšããŠãåäŸè©Šååç©
ã®é µçŽ 掻æ§ã®é»å®³åºŠïŒïŒ ïŒãæ€èšãããäŸè©Šå
åç©ãšé µçŽ 掻æ§ã®é»å®³åºŠã倫ã äžèšã«è¡šç€ºã
ãã äŸè©Šååç© ïŒ 3â²ïŒ4â²âãžããããã·âïŒâïœâããã·ã«ãª
ãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ ïŒ 3â²ïŒ4â²âãžããããã·âïŒâïœâããã«ãã«
ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ ïŒ 3â²ïŒ4â²âãžã¢ã»ããã·âïŒâïœâããã·ã«ãª
ãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³ ïŒ 3â²ïŒ4â²âãžããããªãã«ãªãã·âïŒâïœâã
ãã·ã«ãªãã·âïŒïŒïŒâãžã¡ããã·ãã©ãã³
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒ åŒäžR1ã¯æ°Žé žåºåã¯äœçŽã¢ã«ã³ãã·åºãã
R2ã¯ççŽ æ°ïŒã14ã®ã¢ã«ã³ãã·åºããR3ã¯äœçŽ
ã¢ã«ã³ãã·åºã瀺ãããŸãR4ã¯æ°Žé žåºãççŽ æ°
ïŒã10ã®ã¢ã«ã«ãã€ã«ãªãã·åºãã·ã¯ãã¢ã«ãã«
ã«ã«ããã«ãªãã·åºããã³ãŸã€ã«ãªãã·åºãäœçŽ
ã¢ã«ã³ãã·äœçŽã¢ã«ã³ãã·åºåã¯ããšãã«äœçŽã¢
ã«ã³ãã·åºã瀺ãããŸãïœã¯ïŒãïŒã®æŽæ°ã瀺
ãã ã§è¡šããããæ°èŠãã©ãã³èªå°äœåã³ãã®å¡©ã
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20971383A JPS60100570A (ja) | 1983-11-07 | 1983-11-07 | æ°èŠãã©ãã³èªå°äœ |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20971383A JPS60100570A (ja) | 1983-11-07 | 1983-11-07 | æ°èŠãã©ãã³èªå°äœ |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60100570A JPS60100570A (ja) | 1985-06-04 |
JPH0425268B2 true JPH0425268B2 (ja) | 1992-04-30 |
Family
ID=16577410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP20971383A Granted JPS60100570A (ja) | 1983-11-07 | 1983-11-07 | æ°èŠãã©ãã³èªå°äœ |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60100570A (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2732665B2 (ja) * | 1988-07-08 | 1998-03-30 | æ ªåŒäŒç€Ÿæ¥æ¬èªåè»éšåç·åç 究æ | åžæ°ç®¡å§åæ€åºè£ 眮 |
KR100447918B1 (ko) * | 1996-07-25 | 2005-09-28 | ëìì ìœì£Œìíì¬ | ëì¥ìí¬íšíìì¥êŽë³Žížìì©ìê°ëíëŒë³žë°íëŒë°ë Œíí©ë¬Œ |
FR2778663B1 (fr) | 1998-05-15 | 2001-05-18 | Coletica | Nouveaux esters de flavonoides,leur utilisation en cosmetique, dermopharmacie, en pharmacie et en agro-alimentaire |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5014677A (ja) * | 1973-06-12 | 1975-02-15 | ||
JPS5014676A (ja) * | 1973-06-12 | 1975-02-15 | ||
JPS5014678A (ja) * | 1973-06-12 | 1975-02-15 | ||
JPS5077373A (ja) * | 1973-11-15 | 1975-06-24 | ||
JPS5136457A (ja) * | 1974-09-20 | 1976-03-27 | Eisai Co Ltd | Hekisametokishifurabon no goseiho |
-
1983
- 1983-11-07 JP JP20971383A patent/JPS60100570A/ja active Granted
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5014677A (ja) * | 1973-06-12 | 1975-02-15 | ||
JPS5014676A (ja) * | 1973-06-12 | 1975-02-15 | ||
JPS5014678A (ja) * | 1973-06-12 | 1975-02-15 | ||
JPS5077373A (ja) * | 1973-11-15 | 1975-06-24 | ||
JPS5136457A (ja) * | 1974-09-20 | 1976-03-27 | Eisai Co Ltd | Hekisametokishifurabon no goseiho |
Also Published As
Publication number | Publication date |
---|---|
JPS60100570A (ja) | 1985-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5455252A (en) | Optionally substituted 6,8-quinolines | |
TWI406856B (zh) | 人é¡å ç«çŒºä¹ç æ¯è€è£œä¹æå¶å | |
JP2793195B2 (ja) | ãã³ãŸãã¢ãŸãŒã«èªå°äœ | |
KR0138529B1 (ko) | 칎륎볎ì€í°ëŠŽ ì ë첎 | |
JPH01279866A (ja) | ãããªã³ç³»ã¡ãããã©ã¯ãã³é¡ | |
WO1992019238A1 (en) | Huperzine a analogs | |
JP2005503414A (ja) | ïœïœâïœïœé»å®³è¬ | |
JPH0574587B2 (ja) | ||
EP0611766A1 (fr) | Dérivés de 2-amido-thiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament | |
JP2014001227A (ja) | ãããã³ååç©åã³å»è¬çµæç© | |
EP0205362B1 (fr) | Dérivés quinolylglycinamides, leur procédé de préparation et leur application thérapeutique en tant que psychotropes | |
EP0091795A1 (en) | Olefinic benzimidazoles | |
HU206874B (en) | Process for producing benzopyrane and benzothiopyrane derivatives and pharmaceutical compositions containing them as active component | |
FR2623808A1 (fr) | Nouveaux derives flavonoides (benzyl-4 piperazinyl-1)-2 oxo-2 ethylene substitues, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
JPH0425268B2 (ja) | ||
US5830902A (en) | Quinuclidine derivative having tricyclic hetero condensed ring | |
JPH0434998B2 (ja) | ||
EP1395554B1 (en) | Substituted carbazoles as inhibitors of spla2 | |
CH650254A5 (fr) | Quinolones, leurs procedes de preparation et compositions therapeutiques les contenant. | |
JPH02169571A (ja) | 眮æã¢ãªã«ã¢ãã³èªå°äœ | |
US5229395A (en) | Potential anticancer agents derived from acridine | |
SK86593A3 (en) | Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives | |
JP2012012388A (ja) | å»è¬ | |
JPH0560478B2 (ja) | ||
JPH08269064A (ja) | ããªãããã³èªå°äœ |